<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Neurobiol</journal-id>
      <journal-title-group>
        <journal-title>Molecular Neurobiology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0893-7648</issn>
      <issn pub-type="epub">1559-1182</issn>
      <publisher>
        <publisher-name>Humana Press Inc</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3023855</article-id>
      <article-id pub-id-type="pmid">21161614</article-id>
      <article-id pub-id-type="publisher-id">8155</article-id>
      <article-id pub-id-type="doi">10.1007/s12035-010-8155-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Metamorphosis of Subarachnoid Hemorrhage Research: from Delayed Vasospasm to Early Brain Injury</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Sehba</surname>
            <given-names>Fatima A.</given-names>
          </name>
          <address>
            <phone>+1-212-2416504</phone>
            <fax>+1-212-2410697</fax>
            <email>fatima.sehba@mssm.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pluta</surname>
            <given-names>Ryszard M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>John H.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Neurosurgery, Mount Sinai School of Medicine, Box&#xA0;1136, New York, NY 10029 USA </aff>
        <aff id="Aff2"><label>2</label>Department of Neuroscience, Mount Sinai School of Medicine, Box&#xA0;1136, New York, NY 10029 USA </aff>
        <aff id="Aff3"><label>3</label>Surgical Neurology Branch National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD USA </aff>
        <aff id="Aff4"><label>4</label>JAMA, Chicago, IL USA </aff>
        <aff id="Aff5"><label>5</label>Department of Neurosurgery, Loma Linda University Medical Center, Loma Linda, CA USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>15</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <volume>43</volume>
      <issue>1</issue>
      <fpage>27</fpage>
      <lpage>40</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>10</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>11</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract>
        <p>Delayed vasospasm that develops 3&#x2013;7&#xA0;days after aneurysmal subarachnoid hemorrhage (SAH) has traditionally been considered the most important determinant of delayed ischemic injury and poor outcome. Consequently, most therapies against delayed ischemic injury are directed towards reducing the incidence of vasospasm. The clinical trials based on this strategy, however, have so far claimed limited success; the incidence of vasospasm is reduced without reduction in delayed ischemic injury or improvement in the long-term outcome. This fact has shifted research interest to the early brain injury (first 72&#xA0;h) evoked by SAH. In recent years, several pathological mechanisms that activate within minutes after the initial bleed and lead to early brain injury are identified. In addition, it is found that many of these mechanisms evolve with time and participate in the pathogenesis of delayed ischemic injury and poor outcome. Therefore, a therapy or therapies focused on these early mechanisms may not only prevent the early brain injury but may also help reduce the intensity of later developing neurological complications. This manuscript reviews the pathological mechanisms of early brain injury after SAH and summarizes the status of current therapies.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Subarachnoid hemorrhage</kwd>
        <kwd>Delayed vasospasm</kwd>
        <kwd>Cerebral ischemia</kwd>
        <kwd>Early brain injury</kwd>
        <kwd>Therapeutic interventions</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media, LLC 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>Aneurysmal subarachnoid hemorrhage (SAH) accounts for 5% of all stroke cases and affects up to 30,000 North Americans yearly [<xref ref-type="bibr" rid="CR1">1</xref>]. Early brain injury that occurs at the time of bleed is the leading cause of mortality (30&#x2013;70%) after SAH [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. SAH survivors are at risk of developing delayed cerebral vasospasm, delayed cerebral ischemia, or delayed ischemic neurological deficits during the hospital course [<xref ref-type="bibr" rid="CR2">2</xref>]. Delayed vasospasm develops in approximately 70% of patients between 3 and 14&#xA0;days after SAH [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. For decades, delayed vasospasm has been considered the single and the most important cause of delayed cerebral ischemia and poor outcome [<xref ref-type="bibr" rid="CR3">3</xref>]. The basic and clinical research has been focused on finding strategies to prevent and/or treat delayed vasospasm. However, lack of prevention of delayed cerebral ischemia and improved outcome in a recent clinical trial (CONSCIOUS-1) that successfully prevented the development of delayed vasospasm has raised doubts on the importance of vasospasm in delayed ischemic injury and the outcome after SAH [<xref ref-type="bibr" rid="CR4">4</xref>]. Recent reviews of the experimental and clinical literature indicate that the presence of delayed vasospasm is not a pre-requisite for delayed ischemic injury and poor outcome after SAH [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. In fact, 21% of SAH survivors, who do not develop vasospasm, develop delayed ischemic injury, and only 20&#x2013;30% of those, who do develop delayed vasospasm actually, suffer from delayed ischemic injury [<xref ref-type="bibr" rid="CR2">2</xref>]. It maybe that the pathological mechanisms that activate within minutes after SAH and lead to early brain injury play an important role in the pathogenesis of delayed ischemic injury and poor outcome [<xref ref-type="bibr" rid="CR6">6</xref>]. This manuscript summarizes the animal and human literature addressing the mechanisms of early brain injury after SAH and the importance of its early treatment.</p>
    </sec>
    <sec id="Sec2">
      <title>Early Brain Injury by SAH</title>
      <p>Early brain injury is the product of pathological mechanisms triggered in the brain during the first 72&#xA0;h after SAH (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). These mechanisms are activated at aneurysm rupture and evolve with time affecting the course and the outcome of SAH (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>]. Below, we discuss the pathological mechanisms most pertinent to early brain injury after SAH.
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Mechanisms of early brain injury after SAH: A number of changes in cerebral environment and function occur during the first 72&#xA0;h after SAH. Some of the major changes are listed. See text for explanation. <italic>ICP</italic> intracranial pressure, <italic>CPP</italic> cerebral perfusion pressure, <italic>CBF</italic> cerebral blood flow, <italic>NO</italic> nitric oxide, <italic>NOS</italic> nitric oxide synthase, <italic>ET</italic>-1 endothelin-1</p></caption><graphic xlink:href="12035_2010_8155_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>The timeline of pathological alterations leading to early brain injury after SAH</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Seconds</td><td>Mechanical trauma, ionic and physiological changes</td></tr><tr><td>60&#xA0;min</td><td>Ionic and physiological, biochemical, molecular, and vascular changes persist; cell death; oxidative stress; inflammatory cascade activates</td></tr><tr><td>24&#xA0;h</td><td>Ionic and physiological, biochemical, molecular, and vascular changes persist; cell death; oxidative stress; inflammation</td></tr><tr><td>72&#xA0;h</td><td>Ionic, biochemical, molecular, and vascular changes; cell death; oxidative stress; inflammation</td></tr></tbody></table><table-wrap-foot><p>Shown is the time-dependent activation of pathological mechanisms that participate in early brain injury after SAH. These mechanisms evolve with time and contribute to complications associated with delayed phase of SAH. See text for details</p></table-wrap-foot></table-wrap></p>
      <sec id="Sec3">
        <title>Mechanical Trauma</title>
        <p>The first injury to the brain after the aneurysm rupture is mechanical. This trauma evokes constriction of the artery harboring the ruptured aneurysm and its compression by blood filling in the subarachnoid cisterns [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Sudden rise in intracranial pressure that may reach as high as 2,000&#xA0;mm H<sub>2</sub>O (161.8&#xA0;mmHg) [<xref ref-type="bibr" rid="CR12">12</xref>] stops further bleed and compresses cerebral arteries and tissue. Depending upon the amount released, blood not only stretches the subarachnoid space, but also flows into the branching channels and envelops branches of the conducting artery [<xref ref-type="bibr" rid="CR13">13</xref>]. The stretching of the subarachnoid space by blood is mechanically transferred to the vessels near the aneurysm leading to spasm of surrounding arteries [<xref ref-type="bibr" rid="CR14">14</xref>]. Over the course of its presence, the subarachnoid blood clot evokes the early brain injury [<xref ref-type="bibr" rid="CR15">15</xref>] and the delayed spasm [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
      </sec>
      <sec id="Sec4">
        <title>Altered Cerebral Physiology</title>
        <sec id="Sec5">
          <title>Intracranial Pressure</title>
          <p>Intracranial pressure (ICP) rises when blood released at the time of aneurysm rupture fills up the subarachnoid cisterns displacing the cerebrospinal fluid (CSF). Most awake patients describe this moment as the onset of &#x201C;the worst headache of my life&#x201D; [<xref ref-type="bibr" rid="CR12">12</xref>]. Two patterns of ICP rise are recognized and compress brain tissue by different mechanisms. In the first pattern, observed in most patients, ICP peaks to a value near diastolic blood pressure and then falls and settles near but slightly above the baseline [<xref ref-type="bibr" rid="CR17">17</xref>]. In this pattern, the volume of bleed is small but cerebral edema is present [<xref ref-type="bibr" rid="CR12">12</xref>]. In the second pattern, observed in some patients, ICP remains elevated, due to the mass effect from enlarging hematoma or due to the development of acute hydrocephalus [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. The second pattern of ICP rise is associated with high mortality [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. The terms &#x201C;ischemic-edematous lesion&#x201D; and &#x201C;hemorrhagic-compressive lesion&#x201D; have been used to differentiate the brain compressing forces associated with the two ICP patterns [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. The intensity of ICP rise is linked to hemorrhage volume, obstruction of the CSF outflow, diffuse vasoparalysis, and distal cerebral arteriolar vasodilation. The severity of ICP is associated with changes in cerebral metabolism, inflammation, fall in cerebral blood flow (CBF), and development of early and delayed cerebral ischemia [<xref ref-type="bibr" rid="CR20">20</xref>]. Hence, the extent of ICP rise is often used to predict outcome of SAH [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>] (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>The timeline of physiological alterations during the first 72&#xA0;h after SAH. Within seconds after SAH: ICP rises, CBF and CPP fall, and BP increases [<xref ref-type="bibr" rid="CR17">17</xref>]. Five minutes after SAH: ICP declines towards basal value and CPP and BP recover to the basal value, CBF remains decreased, and CBF autoregulation is impaired [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Sixty minutes after SAH: ICP stabilizes to a new plateau that is above the basal value, CPP and BP have recovered, CBF is still decreased, and CBF autoregulation still impaired [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Twenty-four hours after SAH: ICP is still at the 60-min value, CPP and BP are recovered, CBF is decreased, and CBF autoregulation is still impaired [<xref ref-type="bibr" rid="CR140">140</xref>]. Seventy-two hours after SAH: ICP, CPP, and BP are at baseline [<xref ref-type="bibr" rid="CR140">140</xref>], CBF is recovered or decreased [<xref ref-type="bibr" rid="CR140">140</xref>], and CBF autoregulation is still impaired [<xref ref-type="bibr" rid="CR141">141</xref>]. <italic>Insert</italic>: In animals, the higher the ICP rise at SAH and the lower the 60-min CBF recovery, the smaller the changes of 24&#xA0;h survival [<xref ref-type="bibr" rid="CR142">142</xref>]</p></caption><graphic xlink:href="12035_2010_8155_Fig2_HTML" id="MO2"/></fig></p>
        </sec>
        <sec id="Sec6">
          <title>Cerebral Perfusion Pressure</title>
          <p>CPP falls profoundly during and immediately after SAH. Animal studies indicate that CPP fall is not sufficient to cause perfusion arrest [<xref ref-type="bibr" rid="CR17">17</xref>]. Similarly, in SAH patients, CPP reductions are not clearly associated with poor neurological outcome. Consequently, decreased CPP may contribute to early ischemic brain injury but is not solely responsible for it [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR22">22</xref>].</p>
        </sec>
        <sec id="Sec7">
          <title>Cerebral Blood Flow</title>
          <p>CBF falls after SAH and may or may not recover depending upon the severity of the bleed [<xref ref-type="bibr" rid="CR17">17</xref>]. In animals, CBF reduction after SAH is accompanied by constriction of large cerebral blood vessels [<xref ref-type="bibr" rid="CR23">23</xref>]. By contrast, in humans, little arteriographic evidence of acute arterial spasm is found [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Therefore, initial fall in CBF in humans is often attributed to the brief period of no-reflow, due to elevated ICP and decreased CPP [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
        </sec>
        <sec id="Sec8">
          <title>CBF Autoregulation</title>
          <p>Autoregulatory mechanisms of CBF are frequently impaired after SAH leading to inadequate CBF response to a change in systemic blood pressure (pressure autoregulation) or to a change in partial pressure of carbon dioxide (chemoregulation) [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. In animals, a severe disturbance in autoregulation occurs within 2&#x2013;3&#xA0;h and continues for months after SAH [<xref ref-type="bibr" rid="CR22">22</xref>]. In patients, this impairment is most pronounced during the first 72&#xA0;h and correlates well with the SAH severity [<xref ref-type="bibr" rid="CR27">27</xref>].</p>
        </sec>
      </sec>
      <sec id="Sec9">
        <title>Altered Ionic Homeostasis</title>
        <p>A rapid alteration in ionic homeostasis occurs after SAH and affects especially sodium, potassium, calcium, and magnesium ions. The alteration evokes immediate effects such as vasoconstriction, an electrical activity disturbance, and slowly developing effects, such as activation and expression of proteins, that develop in a delayed fashion but last for a long time. Both of these effects can be detrimental to the injured brain. The timeline of SAH-derived alteration in ionic homeostasis is presented in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>.
<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>The timeline of ionic alterations during the first 72&#xA0;h after SAH</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Time post-SAH</th><th>Ionic changes</th></tr></thead><tbody><tr><td>Within seconds</td><td>Cortical K<sup>2+</sup> &#x2191; and Ca<sup>2+</sup> &#x2193;, EEG amplitude &#x2193;, CSD</td></tr><tr><td>5&#xA0;min</td><td>Cortical K<sup>2+</sup> recovered and Ca<sup>2+</sup> recovered or &#x2191;, EEG amplitude &#x2193;, CSD wave</td></tr><tr><td>24&#xA0;h</td><td>Cortical K<sup>2+</sup> &#x2193; and Ca<sup>2+</sup> &#x2193;, serum Mg<sup>2+</sup> &#x2193;, EEG normal, CSD</td></tr><tr><td>72&#xA0;h</td><td>CSF and serum K<sup>2+</sup> &#x2193;, Ca<sup>2+</sup> &#x2193; and Mg<sup>2+</sup> normal, EEG normal, CSD</td></tr></tbody></table><table-wrap-foot><p>Within seconds after SAH: Cortical K<sup>2+</sup> concentration increases, Ca<sup>2+</sup> decreases, amplitude of brain electrical activity (EEG recording) decreases [<xref ref-type="bibr" rid="CR147">147</xref>], and a wave of cortical depolarization spreads appears (CSD) [<xref ref-type="bibr" rid="CR148">148</xref>]. Five minutes after SAH: Cortical K<sup>2+</sup> concentration recovers, Ca<sup>2+</sup> either recovers or increases above the basal level [<xref ref-type="bibr" rid="CR148">148</xref>], the amplitude of brain electrical activity remains reduced [<xref ref-type="bibr" rid="CR147">147</xref>], and the wave of CSD may or may not be present [<xref ref-type="bibr" rid="CR148">148</xref>]. Twenty-four hours after SAH: Cerebral concentration of K<sup>2+</sup> and Ca<sup>2+</sup> decreases [<xref ref-type="bibr" rid="CR96">96</xref>], serum Mg<sup>2+</sup> concentration decreases [<xref ref-type="bibr" rid="CR32">32</xref>], EEG recovers [<xref ref-type="bibr" rid="CR147">147</xref>], and the wave of CSD may or may not be present [<xref ref-type="bibr" rid="CR28">28</xref>]. Seventy-two hours after SAH: CSF and serum K<sup>2+</sup> [<xref ref-type="bibr" rid="CR149">149</xref>] and Ca<sup>2+</sup> levels decrease (indicating arterial accumulation) [<xref ref-type="bibr" rid="CR150">150</xref>], CSF and serum Mg<sup>2+</sup> concentration normalizes [<xref ref-type="bibr" rid="CR150">150</xref>], EEG recovers [<xref ref-type="bibr" rid="CR147">147</xref>], and the wave of CSD may or may not be present [<xref ref-type="bibr" rid="CR28">28</xref>]</p></table-wrap-foot></table-wrap></p>
        <sec id="Sec10">
          <title>Cortical Spreading Depolarization</title>
          <p>Cortical Spreading Depolarization (CSD) describes a wave of mass neuronal depolarization associated with net influx of cations and water [<xref ref-type="bibr" rid="CR28">28</xref>] and is an effect of breakdown of ion homeostasis in the cerebral cortex. CSD is associated with massive neuronal influx of sodium and calcium. Elevated intracellular calcium is possibly the predominant mediator of neuronal death from ischemia [<xref ref-type="bibr" rid="CR29">29</xref>]. Animal and human studies indicate that CSDs occur early and late after SAH. In human SAH, CSDs can occur as clusters or as isolated events [<xref ref-type="bibr" rid="CR28">28</xref>]. The cooperative study on brain injury and depolarizations (COSBID group) found that clustered CSDs occurred in spatial and temporal correlation to the development of early and delayed brain damage. Electrocortical and regional cerebral blood flow recordings provided evidence of three different neurovascular responses to CSD in SAH patients, similar to the findings in animals: (1) spreading hyperemia, (2) spreading ischemia, and (3) neurovascular uncoupling [<xref ref-type="bibr" rid="CR28">28</xref>]. Experimental evidence suggests that subarachnoid oxyhemoglobin, elevated extracellular potassium, decline in NO availability, glutamate, and endothelin-1 are involved in the development of CSD and spreading ischemia after SAH [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p>
        </sec>
        <sec id="Sec11">
          <title>Decreased Serum Magnesium</title>
          <p>Approximately 38% of the patients admitted within 48&#xA0;h after SAH have abnormally low serum magnesium [<xref ref-type="bibr" rid="CR32">32</xref>]. In animals, decrease in serum and CSF magnesium occurs within minutes and in humans within hours after SAH [<xref ref-type="bibr" rid="CR33">33</xref>]. Because magnesium is a physiological antagonist of calcium and controls the NMDA receptor-derived calcium influx, its decrease after SAH contributes to the rise in cellular calcium. In addition, magnesium dilates blood vessels, inhibits aggregation of platelet, inhibits release of excitatory amino-acids, and inhibits synthesis of endothelin-1 (ET-1) [<xref ref-type="bibr" rid="CR34">34</xref>]. Therefore, decrease in magnesium after SAH exacerbates early brain injury and promotes mechanisms of delayed brain damage.</p>
        </sec>
      </sec>
      <sec id="Sec12">
        <title>Mechanical and Biochemical Alterations</title>
        <p>The timeline of SAH-derived mechanical and biochemical alterations is presented in Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>. These alterations are described in the next three paragraphs.
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>The timeline of biochemical alterations during the first 72&#xA0;h after SAH. Sixty minutes after SAH: Glutamate concentration in cerebral interstitial fluid is increased [<xref ref-type="bibr" rid="CR23">23</xref>], ventricles swell and brain water content increases [<xref ref-type="bibr" rid="CR35">35</xref>], and the status of plasma electrolytes at this time is not established. Twenty-four hours after SAH: Glutamate concentration in cerebral interstitial fluid is still increased [<xref ref-type="bibr" rid="CR143">143</xref>], hydrocephalus [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR96">96</xref>] and hyponatremia [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR96">96</xref>] have set in. Seventy-two hours after SAH: Glutamate concentration cerebral interstitial fluid is still increased [<xref ref-type="bibr" rid="CR143">143</xref>], hydrocephalus [<xref ref-type="bibr" rid="CR35">35</xref>] and hyponatremia [<xref ref-type="bibr" rid="CR41">41</xref>] are still present. <italic>Insert</italic>: SAH patients with large bleeds and poor clinical status at admission are more likely to develop acute hydrocephalus and have poor outcomes [<xref ref-type="bibr" rid="CR38">38</xref>]</p></caption><graphic xlink:href="12035_2010_8155_Fig3_HTML" id="MO3"/></fig></p>
        <sec id="Sec13">
          <title>Hydrocephalus</title>
          <p>Approximately 20% to 30% patients develop acute hydrocephalus within the first 3&#xA0;days after SAH [<xref ref-type="bibr" rid="CR35">35</xref>]. In most cases, these patients have larger hemorrhages, poor cerebral perfusion, and reduced CBF at admission [<xref ref-type="bibr" rid="CR36">36</xref>]. In animals, symptoms of hydrocephalus are present within an hour after initial bleed and are associated with intensity of CBF reduction and cerebral ischemia [<xref ref-type="bibr" rid="CR37">37</xref>]. The mechanisms of acute hydrocephalus include sudden obstruction of cerebrospinal fluid circulation [<xref ref-type="bibr" rid="CR35">35</xref>], presence of blood in the ventricles, hemorrhage from a posterior circulation aneurysm, diffused spread of subarachnoid blood, rebleeding, hypertension, and increased sympathetic activity [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
        </sec>
        <sec id="Sec14">
          <title>Increase in Extracellular Glutamate</title>
          <p>Cerebral glutamate level increases within minutes after SAH and peaks at approximately 40&#xA0;min [<xref ref-type="bibr" rid="CR23">23</xref>]. This biochemical change is associated with the intensity of initial insult [<xref ref-type="bibr" rid="CR39">39</xref>]. An increased interstitial glutamate concentration after SAH is linked to cellular leakage, altered synaptic transmission, blood&#x2013;brain barrier opening, and inhibited glutamate uptake [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
        </sec>
        <sec id="Sec15">
          <title>Hyponatremia</title>
          <p>Hyponatremia is either present in 10% to 30% of SAH patients at admission or develops within 1&#x2013;2&#xA0;days from the initial bleed [<xref ref-type="bibr" rid="CR40">40</xref>]. Cerebral salt-wasting syndrome and inappropriate secretion of anti-diuretic hormone are implicated in its development. SAH-related hyponatremia is difficult to treat and is associated with the risk of developing cerebral ischemia and infarctions [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
        </sec>
      </sec>
      <sec id="Sec16">
        <title>Vascular Pathology</title>
        <p>Cerebral vasculature constricts in response to SAH [<xref ref-type="bibr" rid="CR42">42</xref>&#x2013;<xref ref-type="bibr" rid="CR45">45</xref>]. In animals, constriction of large and small (&#x2264;100&#xA0;&#x3BC;m) parenchymal vessels is visible within minutes after the initial bleed (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>) [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. In humans, vascular imaging is mostly restricted to large vessels; these imaging studies reveal that the large vessels constrict with a delay of 3&#x2013;7&#xA0;days after the SAH. However, more recently, Uhl et al. confirmed constriction of small vessels in patients undergoing surgery within the first 72&#xA0;h after SAH [<xref ref-type="bibr" rid="CR45">45</xref>]. Thus, it appears that the response of small vessels to SAH in humans (constriction) is the same as in animal models.
<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>The timeline of vascular alterations and cell death during the first 72&#xA0;h after SAH</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Time post-SAH</th><th>Pathological changes</th></tr></thead><tbody><tr><td>10&#xA0;min</td><td>Vasoconstriction, endothelial corrugation and detachment from basal lamina, collagen IV degradation, &#x2191; permeability, &#x2193; perfusion, cell death pathway activates</td></tr><tr><td>60&#xA0;min</td><td>Vasoconstriction, endothelium function decreased, collagen IV degradation persists, &#x2191; permeability, &#x2193; perfusion, cell death pathway activates</td></tr><tr><td>24&#xA0;h</td><td>Vasodilation, endothelium detachment, collagen IV degradation persists, &#x2191; permeability, perfusion recovered, cell death in progress</td></tr><tr><td>72&#xA0;h</td><td>Vasospasm, endothelium degeneration, basal lamina destruction, &#x2191; permeability, cell death in progress</td></tr></tbody></table><table-wrap-foot><p>Ten minutes after SAH: Large and small vessels are constricted [<xref ref-type="bibr" rid="CR46">46</xref>], endothelium of parenchymal vessels is detached from the basal lamina (BL) [<xref ref-type="bibr" rid="CR7">7</xref>], collagen IV (the major protein of BL) is degraded [<xref ref-type="bibr" rid="CR49">49</xref>], vascular permeability is increased, and perfusion is decreased [<xref ref-type="bibr" rid="CR53">53</xref>]. Sixty minutes after SAH: Cerebral vessels are still constricted [<xref ref-type="bibr" rid="CR46">46</xref>], endothelial function is decreased [<xref ref-type="bibr" rid="CR7">7</xref>], collagen IV degradation persists [<xref ref-type="bibr" rid="CR49">49</xref>], vascular permeability is increased, and perfusion decreased (Friedrich et al. [<xref ref-type="bibr" rid="CR53">53</xref>]) and mediators of cell death are activated [<xref ref-type="bibr" rid="CR151">151</xref>]. Twenty-four hours after SAH: Cerebral vessels are dilated or at normal diameter [<xref ref-type="bibr" rid="CR46">46</xref>], endothelium is recovering [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], collagen IV is recovering but is still decreased [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR152">152</xref>], vascular permeability is increased, vascular perfusion is recovered or slightly increased [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], and cell death (apoptotic and necrotic) is in progress [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Seventy-two hours after SAH: Large vessels are constricted [<xref ref-type="bibr" rid="CR153">153</xref>], endothelial cells are degenerating [<xref ref-type="bibr" rid="CR153">153</xref>], collagen IV is still decreased [<xref ref-type="bibr" rid="CR50">50</xref>], vascular permeability is increased [<xref ref-type="bibr" rid="CR50">50</xref>], and cell death (autophagy, apoptosis) is in progress [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]</p></table-wrap-foot></table-wrap></p>
        <p>The morphology and function of small vessels is assessed in animals and in autopsy samples from patients who died within the first 72&#xA0;h after SAH. These studies show corrugation, disruption, and detachment of the endothelium from the basement membrane [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Therefore, it is not surprising that therapeutic agents that require a functional endothelium to elicit response are ineffective during the early hours after SAH [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Another morphological alteration found in small vessels after SAH is destruction of the basement membrane [<xref ref-type="bibr" rid="CR49">49</xref>&#x2013;<xref ref-type="bibr" rid="CR51">51</xref>]. Although at present destruction of basement membrane is established in experimental studies only, its pathological consequence&#x2014;increased vessel permeability&#x2014;is established in animals and in humans [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. In most cases, an increase in vascular permeability precedes and correlates well with the development of delayed cerebral ischemia and poor clinical outcome [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR52">52</xref>].</p>
      </sec>
      <sec id="Sec17">
        <title>Cell Death</title>
        <p>Necrosis, apoptosis, and autophagy cell death pathways activate early in the brain after SAH (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>). Cerebral targets of these cell death pathways include brain cells (neurons and glia) and cerebral vasculature (smooth muscle and endothelium) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. It appears that more than one cell death pathway is active at any given time after SAH. For example; Dreier and colleagues found necrotic and apoptotic cell death and cerebral infarction in animals 24&#xA0;h after SAH [<xref ref-type="bibr" rid="CR55">55</xref>]. Similarly, Lee et al. report neuronal apoptosis in the superficial layers of the fronto-basal cortex and autophagy in deep cortical structures of animals 24&#xA0;h after SAH [<xref ref-type="bibr" rid="CR56">56</xref>]. For how long, after SAH, do these cell death pathways remain active is not clear at present. However, animal and human autopsy studies indicate that apoptotic cell death of neurons increases during the first 7&#xA0;days and then decreases by 11&#xA0;days after SAH [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. In SAH animals, the early cell death is associated with neurological deficits [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR58">58</xref>].</p>
      </sec>
      <sec id="Sec18">
        <title>Molecular Alterations</title>
        <p>The timeline of SAH-derived molecular alterations is presented in Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>. These molecular alterations are described below.
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>The timeline of molecular alterations during the first 72h after SAH. Ten minutes after SAH: Cerebral NO level is decreased [<xref ref-type="bibr" rid="CR59">59</xref>] and platelet aggregates are present in parenchymal vessels [<xref ref-type="bibr" rid="CR62">62</xref>]. Sixty minutes after SAH: cerebral NO level remains decreased [<xref ref-type="bibr" rid="CR59">59</xref>], platelet aggregates persist in parenchymal vessels [<xref ref-type="bibr" rid="CR62">62</xref>], plasma ET-1 level increases [<xref ref-type="bibr" rid="CR74">74</xref>], oxidative stress is in progress [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>], and inflammatory cytokines are expressed [<xref ref-type="bibr" rid="CR144">144</xref>]. Three hours after SAH: Cerebral NO level is increasing towards recovery [<xref ref-type="bibr" rid="CR59">59</xref>], platelet aggregates are still present in the cerebral vessels [<xref ref-type="bibr" rid="CR62">62</xref>], oxidative stress persists [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>], and inflammatory cytokines are expressed. Twenty-four hours after SAH: Cerebral NO level increases above basal value [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>], platelet aggregation in parenchymal vessels continues [<xref ref-type="bibr" rid="CR62">62</xref>], plasma ET-1 level remains increased [<xref ref-type="bibr" rid="CR73">73</xref>], oxidative stress persists [<xref ref-type="bibr" rid="CR145">145</xref>], expression of inflammatory cytokine persists [<xref ref-type="bibr" rid="CR144">144</xref>], and their markers appear in serum and CSF [<xref ref-type="bibr" rid="CR88">88</xref>]. Seventy-four hours after SAH: CSF level of NO [<xref ref-type="bibr" rid="CR61">61</xref>] and of ET-1 is increased [<xref ref-type="bibr" rid="CR73">73</xref>], oxidative stress persists [<xref ref-type="bibr" rid="CR145">145</xref>], CSF inflammatory cytokine level remains increased [<xref ref-type="bibr" rid="CR88">88</xref>], and blood platelet count remains decreased indicating activation, sequestration/aggregation in the brain [<xref ref-type="bibr" rid="CR146">146</xref>]. <italic>Insert</italic>: Antioxidant system activity is decreased and lipid peroxidation products accumulate within 72&#xA0;h after SAH and correlate well with poor clinical conditions and outcome [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR145">145</xref>]</p></caption><graphic xlink:href="12035_2010_8155_Fig4_HTML" id="MO4"/></fig></p>
        <sec id="Sec19">
          <title>Nitric Oxide/Nitric Oxide Synthase Pathway</title>
          <p>A time-dependent alteration in nitric oxide (NO)/nitric oxide synthase (NOS) pathway occurs during the first 24&#xA0;h after SAH. In animals, three phases of alteration in cerebral NO are recognized: a decrease within 10&#xA0;min, return to basal value at 3&#xA0;h [<xref ref-type="bibr" rid="CR59">59</xref>], and an increase above basal value at 24&#xA0;h after SAH [<xref ref-type="bibr" rid="CR60">60</xref>]. In humans, due to early timing, the first two phases of cerebral NO alteration are not illustrated; the third phase, presenting an increase in NO 24&#xA0;h after SAH, however, is established [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
          <p>The NO/NOS pathway plays a major role in regulating the cerebral hemodynamic. Therefore, any alteration in this pathway can have pathological consequences. For example, NO regulates CBF and blood pressure by dilating blood vessels and by inhibiting platelet aggregation and leukocyte adherence to the vascular endothelium. After SAH, as cerebral NO level falls, CBF falls, cerebral vessels constrict, platelets aggregate, and neutrophils adhere to the vascular endothelium [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Similarly, the pathological rise in cerebral NO, 24&#xA0;h after SAH, can exacerbate the brain injury. For example, NO as a free radical itself and in the form of peroxynitrite (powerful oxidant) can attack cell membrane; cause damage to the mitochondria, vascular endothelium, and smooth muscle cells [<xref ref-type="bibr" rid="CR64">64</xref>]l; and activate cell death [<xref ref-type="bibr" rid="CR65">65</xref>]. The initial fall and later rise in cerebral NO are linked to pathogenesis of delayed vasospasm and poor clinical outcome after SAH [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. Consequently, alterations in NO occurring during the first 24&#xA0;h after SAH carry acute, delayed, and prolonged consequences.</p>
        </sec>
        <sec id="Sec20">
          <title>Endothelin-1</title>
          <p>ET-1 is a potent vasoconstrictor released by astrocytes and leukocytes in response to inflammation and early ischemia after SAH [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. ET-1 is implicated in early brain injury and in the pathogenesis of delayed vasospasm and delayed ischemic deficits after SAH [<xref ref-type="bibr" rid="CR70">70</xref>&#x2013;<xref ref-type="bibr" rid="CR72">72</xref>]. A number of observations support this concept: (1) ET-1 level increases in serum and plasma within minutes after SAH and expression of its receptors increases 24 to 48&#xA0;h later [<xref ref-type="bibr" rid="CR73">73</xref>&#x2013;<xref ref-type="bibr" rid="CR75">75</xref>]; (2) ET-1 has the capacity to produce long-lasting constriction [<xref ref-type="bibr" rid="CR73">73</xref>]; (3) ET-1 level is increased at the time that cerebral NO is reduced (see above) and thus has a perfect unopposed opportunity to elicit a sustained contraction in cerebral vessels after SAH; and (4) ET-1 creates the degenerative morphological changes in the vascular wall similar to those that occur after SAH [<xref ref-type="bibr" rid="CR76">76</xref>]. Therefore, ET-1 provides yet another mechanism that activates minutes after SAH and has early, delayed, and prolonged consequences.</p>
        </sec>
        <sec id="Sec21">
          <title>Oxidative and Nitrosative Stress</title>
          <p>Animal and human studies indicate that oxygen-free radicals (ROS) are generated early after SAH and consume enzymatic and non-enzymatic antioxidant defense systems [<xref ref-type="bibr" rid="CR77">77</xref>&#x2013;<xref ref-type="bibr" rid="CR79">79</xref>]. ROS are mostly generated during lipid peroxidation and hemoglobin auto oxidation and induce oxidative stress that contributes to rapidly developing early and more slowly developing delayed ischemic injury after SAH [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. The mechanisms of ROS-induced brain injury after SAH include: (1) damage of vascular smooth muscle and endothelium, (2) disruption of blood&#x2013;brain barrier, (3) production of strong spasmogens, and (4) induction of pro-apoptosis enzymes [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. Accordingly, mice that overexpress superoxide dismutase exhibit ameliorated delayed vasospasm and significantly reduced 24-h mortality [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>].</p>
        </sec>
        <sec id="Sec22">
          <title>Inflammation</title>
          <p>Substantial amount of data supports early activation of inflammatory cascade after SAH. Components especially important in post-SAH inflammation and injury include adhesion molecules, cytokines, leukocytes, and complement. Adhesion molecules (such as vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin) are required for leukocyte migration and represent inflammation. In animals, endothelial expression of adhesion molecules and their serum levels increase within 24&#xA0;h after SAH and their selective inhibition improves outcome [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. Similarly, in SAH patients, serum ICAM-1 and VCAM-1 concentration increases at the day of hemorrhage, remains high for 6&#x2013;8&#xA0;days, and associates with delayed ischemic injury [<xref ref-type="bibr" rid="CR84">84</xref>&#x2013;<xref ref-type="bibr" rid="CR86">86</xref>].</p>
          <p>An early increase in pro-inflammatory cytokines (such as interlukin-6, interleukin-1 receptor antagonist, and tumor necrosis factor-alpha) is also noted in the serum and CSF of SAH patients and relates to early and delayed ischemia and poor outcome [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. Similarly, systemic complement, another promoter of inflammation, activates within the first 48&#xA0;h in SAH patients and associates with delayed neurological complications [<xref ref-type="bibr" rid="CR89">89</xref>]. In animals, early inhibition of complement prevents pathogenesis of delayed vasospasm [<xref ref-type="bibr" rid="CR90">90</xref>].</p>
        </sec>
        <sec id="Sec23">
          <title>Platelets</title>
          <p>Platelets activate within minutes after SAH. A reduction in venous jugular platelet count and shape change indicating sequestration and activation is observed 5&#xA0;min after SAH in animals and 48&#xA0;h after ictus in SAH patients [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. Furthermore, platelet aggregates in the lumen of small cerebral vessels are found within 10&#xA0;min after SAH in animals [<xref ref-type="bibr" rid="CR62">62</xref>] and within 2&#xA0;days after SAH in human autopsy studies [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
          <p>The presence of platelets in the small arteries leads to &#x201C;no-reflow&#x201D; phenomenon: the absence of vascular filling after a period of global cerebral ischemia [<xref ref-type="bibr" rid="CR93">93</xref>]. In addition, luminal platelet aggregates activate and promote mechanisms that cause structural injury and functional deficits in small vessels and devastate the already compromised brain. For example, they (1) mechanically obstruct and biochemically constrict (via releasing platelet-derived serotonin, ADP and PDGF) the vessel lumen to promote hypoperfusion [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR94">94</xref>], (2) injure the vascular endothelium to promote further aggregation [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR95">95</xref>], and (3) digest the major protein, collagen IV of the vascular basement membrane (via releasing collagenases such as matrix metalloproteinases-2 and 9) to increase vascular permeability and gain access to the brain parenchyma [<xref ref-type="bibr" rid="CR7">7</xref>]. In brain parenchyma, platelets may activate additional inflammatory mechanisms to further aggravate brain injury after SAH.</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec24">
      <title>Therapeutic Options</title>
      <p>Animal studies demonstrate that treatment of early brain injury improves outcome after SAH. Human data supporting these finding, however, are lacking as delayed vasospasm and delayed ischemic injury remain the focus of treatment in clinics and clinical trials. The success of these clinical trials unfortunately has been limited. It is time that a new strategy for treating SAH, aimed at reducing the progression of early activated injurious mechanisms, identified in the section &#x201C;<xref rid="Sec2" ref-type="sec">Early Brain Injury by SAH</xref>&#x201D;, is considered. As explained earlier, these mechanisms activate within minutes after aneurysm rupture and may evolve with time and contribute to poor outcome.</p>
      <p>Treatment under this new strategy will begin soon after SAH patient is stabilized and will use pharmacological agents that decrease the progression of the mechanisms identified in the section &#x201C;<xref rid="Sec2" ref-type="sec">Early Brain Injury by SAH</xref>&#x201D;. Pharmacological agents may include a vasodilator (such as NO donors, calcium channel blockers, magnesium or ET-1 antagonists) to prevent further constriction, improve CBF, and reduce the intensity of spreading cerebral ischemia and progressing brain injury. Similarly, an antioxidant, anti-inflammatory, or antiplatelet agent may also be used to reduce ongoing inflammation and oxidation stress. In some cases, inhibition of a single mechanism may not provide substantial protection, and an agent or a combination of agents that inhibit multiple injurious mechanisms may be needed. In such a scenario, nitric oxide donors may be of special interest; they dilate cerebral arteries, recover CBF, and inhibit platelet aggregation. Care, off course, will need to be taken not to exacerbate the brain injury. Consequently, stabilization of the patient and continuous monitoring of vital signs, including ICP, CBF, BP, and heart rate, will be of crucial importance for an early treatment to begin and continue. Nevertheless, given the failure of current therapeutic focus in improving outcome, it is clear that the new strategy aimed at prevention of early brain injury to improve SAH outcome needs be considered. The following section discusses the therapies that are found successful in preventing early brain injury in animals and the clinical trials that have used similar treatments against delayed developing complications (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>).
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Therapeutic strategies against early brain injury after SAH: A battery of compounds working via different pathways has been examined against early brain injury after experimental SAH. Many of them have also been tested against delayed vasospasm and DIC. See text for explanation. <italic>ECE</italic> endothelin-converting enzyme, <italic>PKC</italic> protein kinase C, <italic>ERK1</italic>/<italic>2</italic> extracellular signal-regulated kinase, <italic>ET</italic>-<italic>1</italic> endothelin-1, <italic>NO</italic> nitric oxide, <italic>NOS</italic> nitric oxide synthase, <italic>GSNO</italic> S-nitrosoglutathione, <italic>SNP</italic> sodium nitroprusside, <italic>GTN</italic> nitroglycerin, <italic>eNOS</italic> endothelial nitric oxide synthase</p></caption><graphic xlink:href="12035_2010_8155_Fig5_HTML" id="MO5"/></fig></p>
      <sec id="Sec25">
        <title>Calcium Channel Blockers</title>
        <p>Blockade of dihydropyridine-type calcium channel is found beneficial against SAH. Nimodipine is the most common agent used for this purpose. Animal studies show that nimodipine used 30&#xA0;min to 6&#xA0;h after SAH attenuates constriction and improves cerebral blood supply [<xref ref-type="bibr" rid="CR96">96</xref>]. In SAH patients, nimodipine reduces the incidence of ischemic complications and the risk of poor outcome. Nimodipine is approved for use in SAH patients in the USA [<xref ref-type="bibr" rid="CR1">1</xref>]. Current clinical practices call for oral administration within 4&#xA0;days after SAH ictus for 21&#xA0;days [<xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR98">98</xref>].</p>
        <p>The mechanisms underlying the beneficial effects of nimodipine in SAH patients are not clear. However, it is clear that reversal of delayed vasospasm is not one of them, as little reduction in angiographic vasospasm in patients on nimodipine is found [<xref ref-type="bibr" rid="CR1">1</xref>]. Recovery of CBF and vasodilation, leading to cerebral protection, observed in animals, may explain nimodipine&#x2019;s benefits, but remains to be established in SAH patients.</p>
      </sec>
      <sec id="Sec26">
        <title>Endothelin-1 Antagonism</title>
        <p>At least four approaches that block ET-1-mediated constriction of cerebral arteries are studied after SAH. These include: (1) blocking ET-1 biosynthesis [<xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR100">100</xref>], (2) reducing extracellular ET-1 levels [<xref ref-type="bibr" rid="CR101">101</xref>], (3) blocking ET-1 receptors [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>], and (4) inhibiting upregulation of endothelin receptors [<xref ref-type="bibr" rid="CR104">104</xref>]. ET-1 receptor blockade has provided the most promising results. In animal studies, ET-1 receptor antagonists recover CBF when used 60 and 120&#xA0;min after SAH [<xref ref-type="bibr" rid="CR102">102</xref>]. In clinical trials, ET antagonist, Clazosentan, prevents vasospasm but does not improve the quality of life, supporting dissociation between the two measures [<xref ref-type="bibr" rid="CR103">103</xref>]. As ET-1-mediated constriction contributes to brain injury beginning minutes after SAH, perhaps, a treatment strategy that prevents this contribution is warranted to maximize the benefits, improved quality of life, of ET-1 antagonism.</p>
      </sec>
      <sec id="Sec27">
        <title>Magnesium Sulfate</title>
        <p>A number of investigators have studied the effect of increasing cerebral magnesium against brain injury after SAH. Animal studies find that magnesium pretreatment decreases the duration of ischemic depolarization and reduces ischemic brain lesions upon acute SAH [<xref ref-type="bibr" rid="CR105">105</xref>]. Clinical studies have so far examined the safety of magnesium treatment within the first 72&#xA0;h after SAH. These small pilot studies report that continuous intravenous infusion of magnesium to obtain serum magnesium levels of 1.6&#x2013;2.3&#xA0;mmol/L or a rise of CSF magnesium level to 11% to 21% for 10 or 14&#xA0;days is well tolerated [<xref ref-type="bibr" rid="CR106">106</xref>]. Encouraged by the results of pilot studies, a large randomized, placebo-controlled, double-blind, multicenter phase III clinical trial (IMASH) was conducted [<xref ref-type="bibr" rid="CR107">107</xref>]. The results could not confirm clinical benefits of intravenous magnesium infusion over placebo in SAH patients [<xref ref-type="bibr" rid="CR108">108</xref>]. This failure may have resulted from the low CSF penetration of peripherally infused magnesium or a requirement of an even earlier administration to protect brain against injury.</p>
      </sec>
      <sec id="Sec28">
        <title>Antioxidants</title>
        <p>Antioxidants successfully prevent oxidative stress and decrease early brain injury in animals after SAH [<xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR110">110</xref>]. However, clinical studies with the focus on delayed brain injury have not found these compounds effective [<xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR112">112</xref>].</p>
        <p>Methylprednisolone (a synthetic glucocorticoid) and tirilazad mesylate (a 21-aminosteroid) are the most studied antioxidants. In animals, methylprednisolone used early (immediately or 30&#xA0;min) after SAH attenuates CBF reduction and a rise in cerebral resistance [<xref ref-type="bibr" rid="CR113">113</xref>]. In addition, it prevents vasoactive prostanoid and ecosinoid release [<xref ref-type="bibr" rid="CR109">109</xref>], reduces lipid peroxidation, and preserves an antioxidant enzyme system [<xref ref-type="bibr" rid="CR114">114</xref>]. In a recent clinical study, methylprednisolone used within 24 to 48&#xA0;h after SAH for 3&#xA0;days improved 1-year functional outcome [<xref ref-type="bibr" rid="CR111">111</xref>]. This study supports the idea that treating early brain injury after SAH improves outcome.</p>
        <p>Similarly, tirilazad, when used in animals within 3&#xA0;h after SAH prevents CBF and CPP changes [<xref ref-type="bibr" rid="CR110">110</xref>], protects microvascular endothelium and blood&#x2013;brain barrier [<xref ref-type="bibr" rid="CR115">115</xref>]. In clinical trials, tirilazad therapy that began within 34&#x2013;48&#xA0;h after SAH and continued for 10&#xA0;days showed improved outcome and decreased mortality in poor grade (grades IV and V) male patients only [<xref ref-type="bibr" rid="CR116">116</xref>]. However, these results could not be reproduced and a meta-analysis that included five randomized placebo-controlled trials found no evidence that tirilazad reduces the risk of death or disability after SAH [<xref ref-type="bibr" rid="CR112">112</xref>].</p>
        <p>Free radical scavengers&#x2014;ebselen and edaravone&#x2014;are also examined against vasospasm in SAH patients. Little preclinical data exist on the efficacy of ebselen during the early phase of SAH. Experimental data on edaravone (MCI-186) show that its use within 24&#xA0;h after SAH decreases lipid peroxidation (decreases malondialdehyde and increases SOD activity), decreases caspase-3 activation, increases 48&#xA0;h survival, and improves neurological outcome [<xref ref-type="bibr" rid="CR117">117</xref>]. In humans, ebselen and edaravone treatment beginning 4&#xA0;days after SAH is associated with a trend towards lower incidence of vasospasm, cerebral infarction, and delayed ischemic injury [<xref ref-type="bibr" rid="CR118">118</xref>].</p>
      </sec>
      <sec id="Sec29">
        <title>Antiplatelet Agents</title>
        <p>Surprisingly, only little animal and more clinical data are available on the use of antiplatelet agents after SAH. Acetyl salicylic acid (aspirin) and ticlopidine are the most common antiplatelet agents studied after SAH. In vitro and in vivo experimental studies demonstrate that Aspirin prevents prolonged vasoconstriction produced by blood [<xref ref-type="bibr" rid="CR119">119</xref>]. Meta-analysis of the published data shows a trend towards better outcome in patients treated with antiplatelet agents compared with patients who received no antiplatelet agent [<xref ref-type="bibr" rid="CR120">120</xref>]. In a small study, ticlopidine, used after cisternal drainage, reduced platelet aggregation and improved functional outcome [<xref ref-type="bibr" rid="CR121">121</xref>]. At least two studies have examined the outcome in patients who used aspirin prior to or soon after SAH. The results are contradictory. One study found increased hemorrhage size and poor outcome in women who consumed more than 15 adult aspirin tablets per month prior to SAH [<xref ref-type="bibr" rid="CR122">122</xref>]; the other study found a significantly reduced risk of cerebral infarction in patients with significant urinary salicylate level 48&#xA0;h after SAH [<xref ref-type="bibr" rid="CR123">123</xref>]. Clearly, a larger study is needed to ascertain the effect of dose and timing of aspirin intake on the outcome after SAH.</p>
      </sec>
      <sec id="Sec30">
        <title>Nitric Oxide</title>
        <p>The effect of increasing NO bioavailability or prolonging the duration of NO-mediated mechanisms against early brain injury is examined. Methods used to increase NO bioavailability include intracarotid infusion of NO-saturated saline [<xref ref-type="bibr" rid="CR124">124</xref>], administration of an NO donor [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR124">124</xref>&#x2013;<xref ref-type="bibr" rid="CR127">127</xref>], and increase eNOS expression and/or activity [<xref ref-type="bibr" rid="CR128">128</xref>]. S-nitrosoglutathione and nitroglycerin, NONOate, glyceroltrinitrate, and diazeniumdiolate are some of the NO donors studied after SAH [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR125">125</xref>, <xref ref-type="bibr" rid="CR126">126</xref>]. Studies with NO donor find that its early use recovers CBF, dilates large and small cerebral vessels, and prevents excitotoxic glutamate release after SAH [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Approaches used to increase eNOS expression and activity such as pre-SAH statin use [<xref ref-type="bibr" rid="CR129">129</xref>] have also produced beneficial effects&#x2014;reduction in the intensity of arterial spasm 2&#xA0;days after SAH [<xref ref-type="bibr" rid="CR129">129</xref>]. Similarly, patients who were taking statin before SAH exhibit decrease risk of symptomatic vasospasm and significantly lower incidence of cerebral infarctions [<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR131">131</xref>].</p>
        <p>Another approach that prolongs NO-mediated mechanisms is inhibition of cyclic guanosine 3&#x2032;,5&#x2032;-monophosphate (cGMP) degradation by phosphodiesterase [<xref ref-type="bibr" rid="CR132">132</xref>]. cGMP is a mediator of many of NO-induced effects. In animals, inhibition of phosphodiesterase activity improves NO-mediated vasodilatation [<xref ref-type="bibr" rid="CR132">132</xref>]. In SAH patients, papaverine, a non-specific phosphodiesterase inhibitor, is routinely used to dilate constricted arteries during aneurysm surgery and for the treatment of cerebral vasospasm [<xref ref-type="bibr" rid="CR1">1</xref>]. The short half-life and risks associated with this agent, however, outweigh its benefits [<xref ref-type="bibr" rid="CR133">133</xref>].</p>
        <p>Overall, it appears that increasing NO level at the vascular bed is beneficial after SAH, and the sooner this is done the better the outcome is. These experimental findings remain to be duplicated in a clinical setting.</p>
      </sec>
      <sec id="Sec31">
        <title>Statins&#x2014;Acute Treatment</title>
        <p>Statins are hydroxymethylglutaryl coenzyme A reductase inhibitors and potent inhibitors of cholesterol synthesis. In addition, statins inhibit platelet aggregation, reduce excitotoxic effects of glutamate, prevent endothelial and neuronal apoptosis, reduce inflammation, enhance angiogenesis, and upregulate and activate endothelial nitric oxidase synthase and nitric oxide production.</p>
        <p>The effect of acute (within minutes from ictus for animals and within 3&#xA0;days for humans) statin treatment against early and delayed brain injury after SAH has been examined. In animals, simvastatin injected at 30&#xA0;min and 24 and 48&#xA0;h after SAH reduced perivascular granulocyte migration and basilar artery vasospasm [<xref ref-type="bibr" rid="CR134">134</xref>]. Animal studies also show that the protective effects of statin are rapidly lost upon its withdrawal [<xref ref-type="bibr" rid="CR135">135</xref>]. In contrast to animals, some clinical studies do [<xref ref-type="bibr" rid="CR136">136</xref>] and others do not [<xref ref-type="bibr" rid="CR137">137</xref>] find acute statin treatment beneficial in SAH patients. In most of these studies, therapy began within 72&#xA0;h after SAH and continued for 14&#xA0;days, and delayed outcomes such as vasospasm and delayed ischemic injury were evaluated. Recently, two separate groups conducted a meta-analysis on the effect of statin on SAH outcome [<xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR139">139</xref>]. The results are inconsistent. One study found that post-SAH statin use decreases the overall incidences of delayed vasospasm, delayed ischemic injury, and mortality [<xref ref-type="bibr" rid="CR139">139</xref>] , while the other found that this treatment does not improve neurological outcomes [<xref ref-type="bibr" rid="CR138">138</xref>]. Consequently, at present, the effect of post-SAH statin use on outcome remains unresolved. Perhaps a large randomized trial that studies the effect on early brain injury in addition to the delayed complications as an outcome is warranted before a decision on acute statin use after SAH can be made.</p>
      </sec>
    </sec>
    <sec id="Sec32">
      <title>Summary</title>
      <p>Therapies against SAH are designed to treat vasospasm with the ultimate goal of preventing delayed ischemic injury and improving outcome. The success of these therapies in reducing incidence of delayed vasospasm without reduction in delayed ischemic injury and improved quality of life indicates that treating vasospasm alone may not achieve this goal. The results of animal and human studies indicate that mechanisms leading to brain injury activate minutes after SAH and may contribute to the pathogenesis of delayed ischemic injury. Therefore, a therapy that is directed towards inhibiting early brain injury may prove more beneficial in preventing delayed ischemic injury and improving quality of life in this setting.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p content-type="acknowledgment">This work was supported by the American Heart Association grant number GRNT4570012 (FAS), and the National Institutes of Health, grant numbers RO1 NS050576 (FAS) and NS053407 (JHZ), and by the Intramural Research Program (RMP) of the National Institutes of Stroke and Neurological Disorders, NIH.</p>
      <p><bold>Disclosure/Conflict of Interest</bold> None</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>ES</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Batjer</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Dacey</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Dion</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Diringer</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Duldner</surname>
              <given-names>JE</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Harbaugh</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Rosenwasser</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association</article-title>
          <source>Stroke</source>
          <year>2009</year>
          <volume>40</volume>
          <fpage>994</fpage>
          <lpage>1025</lpage>
          <pub-id pub-id-type="doi">10.1161/STROKEAHA.108.191395</pub-id>
          <pub-id pub-id-type="pmid">19164800</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alaraj</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Charbel</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Amin-Hanjani</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Peri-operative measures for treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage</article-title>
          <source>Neurol Res</source>
          <year>2009</year>
          <volume>31</volume>
          <fpage>651</fpage>
          <lpage>659</lpage>
          <pub-id pub-id-type="doi">10.1179/174313209X382395</pub-id>
          <pub-id pub-id-type="pmid">19133166</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kassell</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Colohan</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Nazar</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Cerebral vasospasm following aneurysmal subarachnoid hemorrhage</article-title>
          <source>Stroke</source>
          <year>1985</year>
          <volume>16</volume>
          <fpage>562</fpage>
          <lpage>572</lpage>
          <pub-id pub-id-type="pmid">3895589</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pluta</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Hansen-Schwartz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dreier</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vajkoczy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Macdonald</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Nishizawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kasuya</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wellman</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zauner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dorsch</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ono</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kiris</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Leroux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought</article-title>
          <source>Neurol Res</source>
          <year>2009</year>
          <volume>31</volume>
          <fpage>151</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="doi">10.1179/174313209X393564</pub-id>
          <pub-id pub-id-type="pmid">19298755</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilkins</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Odom</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Intracranial arterial spasm: a clinical analysis</article-title>
          <source>J Neurosurg</source>
          <year>1968</year>
          <volume>29</volume>
          <fpage>121</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1968.29.2.0121</pub-id>
          <pub-id pub-id-type="pmid">5673310</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cahill</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Calvert</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of early brain injury after subarachnoid hemorrhage</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>1341</fpage>
          <lpage>1353</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600283</pub-id>
          <pub-id pub-id-type="pmid">16482081</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedrich</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Flores</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
          <article-title>Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage</article-title>
          <source>Neuroscience</source>
          <year>2010</year>
          <volume>165</volume>
          <fpage>968</fpage>
          <lpage>975</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.10.038</pub-id>
          <pub-id pub-id-type="pmid">19861151</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stein</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Browne</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>XH</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>DI</given-names>
            </name>
          </person-group>
          <article-title>Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study</article-title>
          <source>Neurosurgery</source>
          <year>2006</year>
          <volume>59</volume>
          <fpage>781</fpage>
          <lpage>787</lpage>
          <pub-id pub-id-type="doi">10.1227/01.NEU.0000227519.27569.45</pub-id>
          <pub-id pub-id-type="pmid">16915120</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nau</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bunkowski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bruck</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Neuronal apoptosis in the denate gyrus in humans with subarachnoid hemorrage and cerebral hypoxia</article-title>
          <source>Brain Pathol</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>329</fpage>
          <lpage>336</lpage>
          <pub-id pub-id-type="pmid">12146801</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simeone</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Cotter</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Prolonged experimental cerebral vasospasm</article-title>
          <source>J Neurosurg</source>
          <year>1968</year>
          <volume>29</volume>
          <fpage>357</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1968.29.4.0357</pub-id>
          <pub-id pub-id-type="pmid">4972469</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kapp</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mahaley</surname>
              <given-names>MS</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Odom</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Cerebral arterial spasm. 2. Experimental evaluation of mechanical and humoral factors in pathogenesis</article-title>
          <source>J Neurosurg</source>
          <year>1968</year>
          <volume>29</volume>
          <fpage>339</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1968.29.4.0339</pub-id>
          <pub-id pub-id-type="pmid">4301729</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nornes</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Magnaes</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Intracranial pressure in patients with ruptured saccular aneurysm</article-title>
          <source>J Neurosurg</source>
          <year>1972</year>
          <volume>36</volume>
          <fpage>537</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1972.36.5.0537</pub-id>
          <pub-id pub-id-type="pmid">5026540</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arutiunov</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Majorova</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>Experimental and clinical study of the development of spasm of the cerebral arteries related to subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1970</year>
          <volume>32</volume>
          <fpage>617</fpage>
          <lpage>625</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1970.32.6.0617</pub-id>
          <pub-id pub-id-type="pmid">5429519</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arutiunov</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Majorova</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>The role of mechanical factors in the pathogenesis of short-term and prolonged spasm of the cerebral arteries</article-title>
          <source>J Neurosurg</source>
          <year>1974</year>
          <volume>40</volume>
          <fpage>459</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1974.40.4.0459</pub-id>
          <pub-id pub-id-type="pmid">4814377</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Masago</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Experimental models of subarachnoid hemorrhage in the rat: a refinement of the endovascular filament model</article-title>
          <source>J Neurosci Methods</source>
          <year>2000</year>
          <volume>96</volume>
          <fpage>161</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="doi">10.1016/S0165-0270(00)00156-4</pub-id>
          <pub-id pub-id-type="pmid">10720681</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fisher</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Kistler</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning</article-title>
          <source>Neurosurgery</source>
          <year>1980</year>
          <volume>6</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1227/00006123-198001000-00001</pub-id>
          <pub-id pub-id-type="pmid">7354892</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Germano</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Guarino</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat</article-title>
          <source>Stroke</source>
          <year>1995</year>
          <volume>26</volume>
          <fpage>1086</fpage>
          <lpage>1091</lpage>
          <pub-id pub-id-type="pmid">7762027</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sano</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs</article-title>
          <source>J Neurosurg</source>
          <year>1977</year>
          <volume>46</volume>
          <fpage>454</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1977.46.4.0454</pub-id>
          <pub-id pub-id-type="pmid">845631</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nornes</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm</article-title>
          <source>J Neurosurg</source>
          <year>1973</year>
          <volume>39</volume>
          <fpage>226</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1973.39.2.0226</pub-id>
          <pub-id pub-id-type="pmid">4719700</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hatazawa</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kanno</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Shirane</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yoshimoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yasui</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Cerebral circulation and metabolism in the acute stage of subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2000</year>
          <volume>93</volume>
          <fpage>1014</fpage>
          <lpage>1018</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2000.93.6.1014</pub-id>
          <pub-id pub-id-type="pmid">11117843</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heuer</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Winn</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>LeRoux</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Relationship between intracranial pressure and other clinical variables in patients with aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>408</fpage>
          <lpage>416</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2004.101.3.0408</pub-id>
          <pub-id pub-id-type="pmid">15352597</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jakubowski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Symon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zawirski</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Francis</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>A primate model of subarachnoid hemorrhage: change in regional cerebral blood flow, autoregulation carbon dioxide reactivity, and central conduction time</article-title>
          <source>Stroke</source>
          <year>1982</year>
          <volume>13</volume>
          <fpage>601</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="pmid">6812243</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Chereshnev</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Effects of S-nitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage</article-title>
          <source>Stroke</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>1955</fpage>
          <lpage>1961</lpage>
          <pub-id pub-id-type="pmid">10471450</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weir</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Grace</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rothberg</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Time course of vasospasm in man</article-title>
          <source>J Neurosurg</source>
          <year>1978</year>
          <volume>48</volume>
          <fpage>173</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1978.48.2.0173</pub-id>
          <pub-id pub-id-type="pmid">624965</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grosset</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Straiton</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bullock</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Angiographic and Doppler diagnosis of cerebral artery vasospasm following subarachnoid haemorrhage</article-title>
          <source>Br J Neurosurg</source>
          <year>1993</year>
          <volume>7</volume>
          <fpage>291</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="doi">10.3109/02688699309023812</pub-id>
          <pub-id pub-id-type="pmid">8338650</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grote</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hassler</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>The critical first minutes after subarachnoid hemorrhage</article-title>
          <source>Neurosurgery</source>
          <year>1988</year>
          <volume>22</volume>
          <fpage>654</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="doi">10.1227/00006123-198804000-00006</pub-id>
          <pub-id pub-id-type="pmid">3287211</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmieder</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Moller</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Engelhardt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Scholz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schregel</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Christmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Harders</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Dynamic cerebral autoregulation in patients with ruptured and unruptured aneurysms after induction of general anesthesia</article-title>
          <source>Zentralbl Neurochir</source>
          <year>2006</year>
          <volume>67</volume>
          <fpage>81</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2006-933374</pub-id>
          <pub-id pub-id-type="pmid">16673240</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dreier</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Major</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Manning</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Woitzik</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Drenckhahn</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Steinbrink</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tolias</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Oliveira-Ferreira</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Fabricius</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hartings</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Vajkoczy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lauritzen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dirnagl</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bohner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Strong</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage</article-title>
          <source>Brain</source>
          <year>2009</year>
          <volume>132</volume>
          <fpage>1866</fpage>
          <lpage>1881</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awp102</pub-id>
          <pub-id pub-id-type="pmid">19420089</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gwag</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Canzoniero</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Sensi</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Demaro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Jacquin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons</article-title>
          <source>Neuroscience</source>
          <year>1999</year>
          <volume>90</volume>
          <fpage>1339</fpage>
          <lpage>1348</lpage>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(98)00508-9</pub-id>
          <pub-id pub-id-type="pmid">10338301</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dreier</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Windmuller</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Petzold</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lindauer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Einhaupl</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Dirnagl</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats</article-title>
          <source>Neurosurgery</source>
          <year>2002</year>
          <volume>51</volume>
          <fpage>1457</fpage>
          <lpage>1465</lpage>
          <pub-id pub-id-type="doi">10.1097/00006123-200212000-00017</pub-id>
          <pub-id pub-id-type="pmid">12445352</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petzold</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Einhaupl</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Dirnagl</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Dreier</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space</article-title>
          <source>Ann Neurol</source>
          <year>2003</year>
          <volume>54</volume>
          <fpage>591</fpage>
          <lpage>598</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.10723</pub-id>
          <pub-id pub-id-type="pmid">14595648</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergh</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Algra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sprenkel</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Tulleken</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Rinkel</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Hypomagnesemia after aneurysmal subarachnoid hemorrhage</article-title>
          <source>Neurosurgery</source>
          <year>2003</year>
          <volume>52</volume>
          <fpage>276</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="doi">10.1227/01.NEU.0000043984.42487.0E</pub-id>
          <pub-id pub-id-type="pmid">12535355</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Altura</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Memon</surname>
              <given-names>ZI</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Silverman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cracco</surname>
              <given-names>RQ</given-names>
            </name>
            <name>
              <surname>Altura</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells</article-title>
          <source>Neurosci Lett</source>
          <year>1997</year>
          <volume>230</volume>
          <fpage>37</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1016/S0304-3940(97)00471-0</pub-id>
          <pub-id pub-id-type="pmid">9259458</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berthon</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Laurant</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fellmann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Berthelot</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>24</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1097/00005344-200307000-00004</pub-id>
          <pub-id pub-id-type="pmid">12827022</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Milhorat</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
          <article-title>Acute hydrocephalus after aneurysmal subarachnoid hemorrhage</article-title>
          <source>Neurosurgery</source>
          <year>1987</year>
          <volume>20</volume>
          <fpage>15</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1227/00006123-198701000-00004</pub-id>
          <pub-id pub-id-type="pmid">3808257</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asch</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Schaaf</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Rinkel</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Acute hydrocephalus and cerebral perfusion after aneurysmal subarachnoid hemorrhage</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2010</year>
          <volume>31</volume>
          <fpage>67</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.3174/ajnr.A1748</pub-id>
          <pub-id pub-id-type="pmid">19850767</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kamiya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kuyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Symon</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>An experimental study of the acute stage of subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1983</year>
          <volume>59</volume>
          <fpage>917</fpage>
          <lpage>924</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1983.59.6.0917</pub-id>
          <pub-id pub-id-type="pmid">6415244</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorai</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Hynan</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Kopitnik</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Samson</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage</article-title>
          <source>Neurosurgery</source>
          <year>2003</year>
          <volume>52</volume>
          <fpage>763</fpage>
          <lpage>769</lpage>
          <pub-id pub-id-type="doi">10.1227/01.NEU.0000053222.74852.2D</pub-id>
          <pub-id pub-id-type="pmid">12657171</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Enblad</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Valtysson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Andersson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lilja</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Valind</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Antoni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Langstrom</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hillered</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>1996</year>
          <volume>16</volume>
          <fpage>637</fpage>
          <lpage>644</lpage>
          <pub-id pub-id-type="doi">10.1097/00004647-199607000-00014</pub-id>
          <pub-id pub-id-type="pmid">8964803</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berendes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cullen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Prien</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Aken</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Horsthemke</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schulte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wild</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Scherer</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage</article-title>
          <source>Lancet</source>
          <year>1997</year>
          <volume>349</volume>
          <fpage>245</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(96)08093-2</pub-id>
          <pub-id pub-id-type="pmid">9014912</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wijdicks</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Vermeulen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haaf</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Hijdra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Gijn</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm</article-title>
          <source>Ann Neurol</source>
          <year>1985</year>
          <volume>18</volume>
          <fpage>211</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.410180208</pub-id>
          <pub-id pub-id-type="pmid">4037761</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pennings</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Bouma</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Ince</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Direct observation of the human cerebral microcirculation during aneurysm surgery reveals increased arteriolar contractility</article-title>
          <source>Stroke</source>
          <year>2004</year>
          <volume>35</volume>
          <fpage>1284</fpage>
          <lpage>1288</lpage>
          <pub-id pub-id-type="doi">10.1161/01.STR.0000126039.91400.cb</pub-id>
          <pub-id pub-id-type="pmid">15087565</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hatake</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wakabayashi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kakishita</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hishida</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage</article-title>
          <source>Stroke</source>
          <year>1992</year>
          <volume>23</volume>
          <fpage>1111</fpage>
          <lpage>1116</lpage>
          <pub-id pub-id-type="pmid">1636187</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Flores</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Britz</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Winn</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A(2A) receptors in early ischemic vascular injury after subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2010</year>
          <volume>113</volume>
          <issue>4</issue>
          <fpage>826</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="doi">10.3171/2009.9.JNS09802</pub-id>
          <pub-id pub-id-type="pmid">19895201</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uhl</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lehmberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Steiger</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Messmer</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging</article-title>
          <source>Neurosurgery</source>
          <year>2003</year>
          <volume>52</volume>
          <fpage>1307</fpage>
          <lpage>1315</lpage>
          <pub-id pub-id-type="doi">10.1227/01.NEU.0000065154.04824.9E</pub-id>
          <pub-id pub-id-type="pmid">12762876</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Makonnen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Acute cerebral vascular injury occurs after subarachnoid hemorrhage and can be prevented by administration of a nitric oxide donor</article-title>
          <source>J Neurosurg</source>
          <year>2007</year>
          <volume>106</volume>
          <fpage>321</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2007.106.2.321</pub-id>
          <pub-id pub-id-type="pmid">17410718</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Metais</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Comunale</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Sellke</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage</article-title>
          <source>Anesth Analg</source>
          <year>2001</year>
          <volume>92</volume>
          <issue>4</issue>
          <fpage>990</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="doi">10.1097/00000539-200104000-00035</pub-id>
          <pub-id pub-id-type="pmid">11273938</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bevan</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Bevan</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Walters</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Wellman</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Functional changes in human pial arteries (300 to 900 micrometer ID) within 48&#xA0;hours of aneurysmal subarachnoid hemorrhage</article-title>
          <source>Stroke</source>
          <year>1998</year>
          <volume>29</volume>
          <fpage>2575</fpage>
          <lpage>2579</lpage>
          <pub-id pub-id-type="pmid">9836770</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Mostafa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Knopman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>V</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Acute alterations in microvascular basal lamina after subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>633</fpage>
          <lpage>640</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2004.101.4.0633</pub-id>
          <pub-id pub-id-type="pmid">15481718</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scholler</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Trinkl</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klopotowski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thal</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Plesnila</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Trabold</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hamann</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Schmid-Elsaesser</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zausinger</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Characterization of microvascular basal lamina damage and blood&#x2013;brain barrier dysfunction following subarachnoid hemorrhage in rats</article-title>
          <source>Brain Res</source>
          <year>2007</year>
          <volume>1142</volume>
          <fpage>237</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2007.01.034</pub-id>
          <pub-id pub-id-type="pmid">17303089</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yatsushige</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ostrowski</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Tsubokawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Colohan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage</article-title>
          <source>J Neurosci Res</source>
          <year>2007</year>
          <volume>85</volume>
          <fpage>1436</fpage>
          <lpage>1448</lpage>
          <pub-id pub-id-type="doi">10.1002/jnr.21281</pub-id>
          <pub-id pub-id-type="pmid">17410600</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Germano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>d&#x2019;Avella</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Imperatore</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Caruso</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tomasello</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Time-course of blood&#x2013;brain barrier permeability changes after experimental subarachnoid haemorrhage</article-title>
          <source>Acta Neurochir</source>
          <year>2000</year>
          <volume>142</volume>
          <fpage>575</fpage>
          <lpage>580</lpage>
          <pub-id pub-id-type="doi">10.1007/s007010050472</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedrich</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Flores</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
          <article-title>Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage</article-title>
          <source>Brain Res</source>
          <year>2010</year>
          <volume>1354</volume>
          <fpage>179</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2010.07.040</pub-id>
          <pub-id pub-id-type="pmid">20654597</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Calvert</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Neurovascular protection reduces early brain injury after subarachnoid hemorrhage</article-title>
          <source>Stroke</source>
          <year>2004</year>
          <volume>35</volume>
          <fpage>2412</fpage>
          <lpage>2417</lpage>
          <pub-id pub-id-type="doi">10.1161/01.STR.0000141162.29864.e9</pub-id>
          <pub-id pub-id-type="pmid">15322302</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dreier</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Ebert</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Priller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Megow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lindauer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Klee</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Reuter</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Imai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Einhaupl</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Victorov</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Dirnagl</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage?</article-title>
          <source>J Neurosurg</source>
          <year>2000</year>
          <volume>93</volume>
          <fpage>658</fpage>
          <lpage>666</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2000.93.4.0658</pub-id>
          <pub-id pub-id-type="pmid">11014545</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sagher</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Keep</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hua</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Activated autophagy pathway in experimental subarachnoid hemorrhage</article-title>
          <source>Brain Res</source>
          <year>2009</year>
          <volume>1287</volume>
          <fpage>126</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2009.06.028</pub-id>
          <pub-id pub-id-type="pmid">19538949</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prunell</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Svendgaard</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Alkass</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mathiesen</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Delayed cell death related to acute cerebral blood flow changes following subarachnoid hemorrhage in the rat brain</article-title>
          <source>J Neurosurg</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>1046</fpage>
          <lpage>1054</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2005.102.6.1046</pub-id>
          <pub-id pub-id-type="pmid">16028764</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cahill</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Calvert</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Marcantonio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>p53 may play an orchestrating role in apoptotic cell death after experimental subarachnoid hemorrhage</article-title>
          <source>Neurosurgery</source>
          <year>2007</year>
          <volume>60</volume>
          <fpage>531</fpage>
          <lpage>545</lpage>
          <pub-id pub-id-type="doi">10.1227/01.NEU.0000249287.99878.9B</pub-id>
          <pub-id pub-id-type="pmid">17327799</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Chereshnev</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>604</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="doi">10.1097/00004647-200003000-00018</pub-id>
          <pub-id pub-id-type="pmid">10724124</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yatsushige</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Calvert</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Cahill</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Limited role of inducible nitric oxide synthase in blood&#x2013;brain barrier function after experimental subarachnoid hemorrhage</article-title>
          <source>J Neurotrauma</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>1874</fpage>
          <lpage>1882</lpage>
          <pub-id pub-id-type="doi">10.1089/neu.2006.23.1874</pub-id>
          <pub-id pub-id-type="pmid">17184195</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Moochhala</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yeo</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Ong</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>PY</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide and subarachnoid hemorrhage: elevated level in cerebrospinal fluid and their implications</article-title>
          <source>Neurosurgery</source>
          <year>2001</year>
          <volume>49</volume>
          <fpage>622</fpage>
          <lpage>626</lpage>
          <pub-id pub-id-type="doi">10.1097/00006123-200109000-00016</pub-id>
          <pub-id pub-id-type="pmid">11523672</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehba</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Mustafa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Acute microvascular platelet aggregation after subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>1094</fpage>
          <lpage>1100</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2005.102.6.1094</pub-id>
          <pub-id pub-id-type="pmid">16028769</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <mixed-citation publication-type="other">Flores R, Muller A, Friedrich V, and Sehba FA (2009) Neutrophils in early vascular injury after subarachnoid hemorrhage (SAH). Society for Neurosciences abstracts; Poster 51.5/I20</mixed-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moro</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bolanos</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Lizasoain</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial respiratory chain and free radical generation in stroke</article-title>
          <source>Free Radic Biol Med</source>
          <year>2005</year>
          <volume>39</volume>
          <fpage>1291</fpage>
          <lpage>1304</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2005.07.010</pub-id>
          <pub-id pub-id-type="pmid">16257638</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szabo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>VL</given-names>
            </name>
          </person-group>
          <article-title>Role of poly(ADP-ribose) synthetase in inflammation and ischaemia&#x2013;reperfusion</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>1998</year>
          <volume>19</volume>
          <fpage>287</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="doi">10.1016/S0165-6147(98)01193-6</pub-id>
          <pub-id pub-id-type="pmid">9703762</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pluta</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Oldfield</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Boock</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1997</year>
          <volume>87</volume>
          <fpage>746</fpage>
          <lpage>751</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1997.87.5.0746</pub-id>
          <pub-id pub-id-type="pmid">9347984</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pluta</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Dejam</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grimes</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gladwin</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Oldfield</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <article-title>Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage</article-title>
          <source>Jama</source>
          <year>2005</year>
          <volume>293</volume>
          <fpage>1477</fpage>
          <lpage>1484</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.293.12.1477</pub-id>
          <pub-id pub-id-type="pmid">15784871</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pluta</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Boock</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Afshar</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Clouse</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bacic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ehrenreich</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oldfield</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <article-title>Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1997</year>
          <volume>87</volume>
          <fpage>287</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1997.87.2.0287</pub-id>
          <pub-id pub-id-type="pmid">9254095</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fassbender</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hodapp</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rossol</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bertsch</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schmeck</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schutt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fritzinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vajkoczy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wendel-Wellner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ragoschke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kuehl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Brunner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schurer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schmiedeck</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hennerici</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes</article-title>
          <source>Stroke</source>
          <year>2000</year>
          <volume>31</volume>
          <fpage>2971</fpage>
          <lpage>2975</lpage>
          <pub-id pub-id-type="pmid">11108758</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seifert</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Endothelin and subarachnoid hemorrhage: an overview</article-title>
          <source>Neurosurgery</source>
          <year>1998</year>
          <volume>43</volume>
          <fpage>863</fpage>
          <lpage>875</lpage>
          <pub-id pub-id-type="doi">10.1097/00006123-199810000-00083</pub-id>
          <pub-id pub-id-type="pmid">9766314</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Juvela</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2000</year>
          <volume>92</volume>
          <fpage>390</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2000.92.3.0390</pub-id>
          <pub-id pub-id-type="pmid">10701524</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ostrowski</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Colohan</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanisms of early brain injury after subarachnoid hemorrhage</article-title>
          <source>Neurol Res</source>
          <year>2006</year>
          <volume>28</volume>
          <fpage>399</fpage>
          <lpage>414</lpage>
          <pub-id pub-id-type="doi">10.1179/016164106X115008</pub-id>
          <pub-id pub-id-type="pmid">16759443</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kobayashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ide</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ishii</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kabuto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Handa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Endothelin-1 levels in plasma and cerebrospinal fluid following subarachnoid haemorrhage</article-title>
          <source>J Clin Neurosci</source>
          <year>1995</year>
          <volume>2</volume>
          <fpage>252</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="doi">10.1016/S0967-5868(95)80011-5</pub-id>
          <pub-id pub-id-type="pmid">18638823</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Josko</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hendryk</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jedrzejowska-Szypula</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gwozdz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>ZS</given-names>
            </name>
            <name>
              <surname>Gawlik</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Influence endothelin ETA receptor antagonist&#x2014;BQ-123&#x2014;on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage</article-title>
          <source>J Physiol Pharmacol</source>
          <year>1998</year>
          <volume>49</volume>
          <fpage>367</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="pmid">9789790</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vikman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Beg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khurana</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Hansen-Schwartz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Edvinsson</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat</article-title>
          <source>J Neurosurg</source>
          <year>2006</year>
          <volume>105</volume>
          <fpage>438</fpage>
          <lpage>444</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2006.105.3.438</pub-id>
          <pub-id pub-id-type="pmid">16961140</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kasuya</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Weir</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Stefansson</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells</article-title>
          <source>J Neurosurg</source>
          <year>1993</year>
          <volume>79</volume>
          <fpage>892</fpage>
          <lpage>898</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1993.79.6.0892</pub-id>
          <pub-id pub-id-type="pmid">7504096</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaetani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Marzatico</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rodriguez y Baena</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pacchiarini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vigano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Grignani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Crivellari</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Benzi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Arachidonic acid metabolism and pathophysiologic aspects of subarachnoid hemorrhage in rats</article-title>
          <source>Stroke</source>
          <year>1990</year>
          <volume>21</volume>
          <fpage>328</fpage>
          <lpage>332</lpage>
          <pub-id pub-id-type="pmid">2106176</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marzatico</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gaetani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cafe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Spanu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rodriguez y Baena</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Antioxidant enzymatic activities after experimental subarachnoid hemorrhage in rats</article-title>
          <source>Acta Neurol Scand</source>
          <year>1993</year>
          <volume>87</volume>
          <fpage>62</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0404.1993.tb04077.x</pub-id>
          <pub-id pub-id-type="pmid">8424314</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Tsay</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Yen</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans</article-title>
          <source>Free Radic Biol Med</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>1466</fpage>
          <lpage>1473</lpage>
          <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2005.12.019</pub-id>
          <pub-id pub-id-type="pmid">16631536</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Endo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nito</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kamada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Reduction in oxidative stress by superoxide dismutase overexpression attenuates acute brain injury after subarachnoid hemorrhage via activation of Akt/glycogen synthase kinase-3beta survival signaling</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>975</fpage>
          <lpage>982</lpage>
          <pub-id pub-id-type="pmid">16969382</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kamii</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kinouchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Akabane</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshimoto</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase</article-title>
          <source>Stroke</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>867</fpage>
          <lpage>871</lpage>
          <pub-id pub-id-type="pmid">10187893</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Handa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsuchida</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats</article-title>
          <source>Acta Neurochir (Wien)</source>
          <year>1995</year>
          <volume>132</volume>
          <fpage>92</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01404854</pub-id>
          <pub-id pub-id-type="pmid">7754866</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Dumont</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Calisaneller</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Hwong</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm</article-title>
          <source>Surg Neurol</source>
          <year>2005</year>
          <volume>64</volume>
          <fpage>201</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="doi">10.1016/j.surneu.2005.04.038</pub-id>
          <pub-id pub-id-type="pmid">16099244</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mack</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Mocco</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hoh</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Choudhri</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Kreiter</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Lozier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Opperman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Poisik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yorgason</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Solomon</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2002</year>
          <volume>96</volume>
          <fpage>71</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2002.96.1.0071</pub-id>
          <pub-id pub-id-type="pmid">11794607</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kubo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ogasawara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kakino</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kashimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tomitsuka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sugawara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Serum inflammatory adhesion molecules and high-sensitivity C-reactive protein correlates with delayed ischemic neurologic deficits after subarachnoid hemorrhage</article-title>
          <source>Surg Neurol</source>
          <year>2008</year>
          <volume>69</volume>
          <fpage>592</fpage>
          <lpage>596</lpage>
          <pub-id pub-id-type="doi">10.1016/j.surneu.2008.02.014</pub-id>
          <pub-id pub-id-type="pmid">18486699</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mocco</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Lozier</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Laufer</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kreiter</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Sciacca</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Solomon</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>ES</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2002</year>
          <volume>97</volume>
          <fpage>537</fpage>
          <lpage>541</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2002.97.3.0537</pub-id>
          <pub-id pub-id-type="pmid">12296636</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mathiesen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Edner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ulfarsson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Andersson</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1997</year>
          <volume>87</volume>
          <fpage>215</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1997.87.2.0215</pub-id>
          <pub-id pub-id-type="pmid">9254084</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gruber</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rossler</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Graninger</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Donner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Illievich</surname>
              <given-names>MU</given-names>
            </name>
            <name>
              <surname>Czech</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg Anesthesiol</source>
          <year>2000</year>
          <volume>12</volume>
          <fpage>297</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="doi">10.1097/00008506-200010000-00001</pub-id>
          <pub-id pub-id-type="pmid">11147377</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kasuya</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1989</year>
          <volume>71</volume>
          <fpage>741</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1989.71.5.0741</pub-id>
          <pub-id pub-id-type="pmid">2809729</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>German</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Giclas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Watral</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bednar</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Systemic complement depletion inhibits experimental cerebral vasospasm</article-title>
          <source>Neurosurgery</source>
          <year>1996</year>
          <volume>39</volume>
          <fpage>141</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="doi">10.1097/00006123-199607000-00028</pub-id>
          <pub-id pub-id-type="pmid">8805150</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirashima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hamada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kurimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Origasa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Endo</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>882</fpage>
          <lpage>887</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2005.102.5.0882</pub-id>
          <pub-id pub-id-type="pmid">15926714</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Denton</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Dugdale</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>An assessment of early platelet activity in experimental subarachnoid hemorrhage and middle cerebral artery thrombosis in the cat</article-title>
          <source>Stroke</source>
          <year>1971</year>
          <volume>2</volume>
          <fpage>268</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="pmid">5111575</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abumiya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fitridge</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mazur</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Copeland</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Koziol</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Tschopp</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Pierschbacher</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Zoppo</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia</article-title>
          <source>Stroke</source>
          <year>2000</year>
          <volume>31</volume>
          <fpage>1402</fpage>
          <lpage>1409</lpage>
          <pub-id pub-id-type="pmid">10835463</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Copeland</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tung</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Zoppo</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion</article-title>
          <source>Stroke</source>
          <year>1994</year>
          <volume>25</volume>
          <fpage>202</fpage>
          <lpage>211</lpage>
          <pub-id pub-id-type="pmid">7505494</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clower</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Yoshioka</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Honma</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Pathological changes in cerebral arteries following experimental subarachnoid hemorrhage: role of blood platelets</article-title>
          <source>Anat Rec</source>
          <year>1988</year>
          <volume>220</volume>
          <fpage>161</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1002/ar.1092200207</pub-id>
          <pub-id pub-id-type="pmid">3354858</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>ZL</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xiu</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage</article-title>
          <source>Clin Hemorheol Microcirc</source>
          <year>2003</year>
          <volume>29</volume>
          <fpage>337</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">14724359</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorhout Mees</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Rinkel</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Feigin</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Algra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bergh</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Vermeulen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gijn</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Calcium antagonists for aneurysmal subarachnoid hemorrhage</article-title>
          <source>Stroke</source>
          <year>2008</year>
          <volume>39</volume>
          <fpage>514</fpage>
          <lpage>515</lpage>
          <pub-id pub-id-type="doi">10.1161/STROKEAHA.107.496802</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <mixed-citation publication-type="other">Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, and van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev CD000277</mixed-citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Onoda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ono</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ogihara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shiota</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Asari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ohmoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ninomiya</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model</article-title>
          <source>J Neurosurg</source>
          <year>1996</year>
          <volume>85</volume>
          <fpage>846</fpage>
          <lpage>852</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1996.85.5.0846</pub-id>
          <pub-id pub-id-type="pmid">8893723</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caner</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Arthur</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jeng</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Lappe</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Kassell</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1996</year>
          <volume>85</volume>
          <fpage>917</fpage>
          <lpage>922</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1996.85.5.0917</pub-id>
          <pub-id pub-id-type="pmid">8893732</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaura</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Tani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Minami</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shindo</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Endothelin-1 of canine basilar artery in vasospasm</article-title>
          <source>J Neurosurg</source>
          <year>1992</year>
          <volume>76</volume>
          <fpage>99</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1992.76.1.0099</pub-id>
          <pub-id pub-id-type="pmid">1727175</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clozel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection</article-title>
          <source>Life Sci</source>
          <year>1993</year>
          <volume>52</volume>
          <fpage>825</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="doi">10.1016/0024-3205(93)90081-D</pub-id>
          <pub-id pub-id-type="pmid">8437512</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macdonald</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Kassell</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ruefenacht</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schmiedek</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Weidauer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Roux</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pasqualin</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial</article-title>
          <source>Stroke</source>
          <year>2008</year>
          <volume>39</volume>
          <fpage>3015</fpage>
          <lpage>3021</lpage>
          <pub-id pub-id-type="doi">10.1161/STROKEAHA.108.519942</pub-id>
          <pub-id pub-id-type="pmid">18688013</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beg</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Hansen-Schwartz</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Vikman</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Edvinsson</surname>
              <given-names>LI</given-names>
            </name>
          </person-group>
          <article-title>ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>846</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600236</pub-id>
          <pub-id pub-id-type="pmid">16251886</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergh</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Zuur</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Kamerling</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Asseldonk</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Rinkel</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Tulleken</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Nicolay</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2002</year>
          <volume>97</volume>
          <fpage>416</fpage>
          <lpage>422</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2002.97.2.0416</pub-id>
          <pub-id pub-id-type="pmid">12186471</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKee</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Brewer</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Macy</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Borel</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Magnesium neuroprotection is limited in humans with acute brain injury</article-title>
          <source>Neurocrit Care</source>
          <year>2005</year>
          <volume>2</volume>
          <fpage>342</fpage>
          <lpage>351</lpage>
          <pub-id pub-id-type="doi">10.1385/NCC:2:3:342</pub-id>
          <pub-id pub-id-type="pmid">16159086</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Poon</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Boet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gin</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Magnesium therapy within 48&#xA0;hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea</article-title>
          <source>Neurol Res</source>
          <year>2006</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>431</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="doi">10.1179/016164106X115035</pub-id>
          <pub-id pub-id-type="pmid">16759446</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Poon</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Boet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial</article-title>
          <source>Stroke</source>
          <year>2010</year>
          <volume>41</volume>
          <fpage>921</fpage>
          <lpage>926</lpage>
          <pub-id pub-id-type="doi">10.1161/STROKEAHA.109.571125</pub-id>
          <pub-id pub-id-type="pmid">20378868</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaetani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Marzatico</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Renault</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fulle</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lombardi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ferlenga</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rodriguez y Baena</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>High-dose methylprednisolone and &#x2018;ex vivo&#x2019; release of eicosanoids after experimental subarachnoid haemorrhage</article-title>
          <source>Neurol Res</source>
          <year>1990</year>
          <volume>12</volume>
          <fpage>111</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">1974699</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Effects of the nonglucocorticoid 21-aminosteroid U74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage</article-title>
          <source>Exp Neurol</source>
          <year>1988</year>
          <volume>102</volume>
          <fpage>244</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="doi">10.1016/0014-4886(88)90100-8</pub-id>
          <pub-id pub-id-type="pmid">3181364</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Graftieaux</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Sercombe</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hettler</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Scherpereel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rousseaux</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2010</year>
          <volume>112</volume>
          <fpage>681</fpage>
          <lpage>688</lpage>
          <pub-id pub-id-type="doi">10.3171/2009.4.JNS081377</pub-id>
          <pub-id pub-id-type="pmid">19522571</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Tirilazad for aneurysmal subarachnoid haemorrhage</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>CD006778</fpage>
          <pub-id pub-id-type="pmid">20166088</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Attenuation of progressive brain hypoperfusion following experimental subarachnoid hemorrhage by large intravenous doses of methylprednisolone</article-title>
          <source>Exp Neurol</source>
          <year>1988</year>
          <volume>99</volume>
          <fpage>594</fpage>
          <lpage>606</lpage>
          <pub-id pub-id-type="doi">10.1016/0014-4886(88)90176-8</pub-id>
          <pub-id pub-id-type="pmid">3342842</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lombardi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gaetani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Marzatico</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cafe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rodriguez y Baena</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Effect of high-dose methylprednisolone on anti-oxidant enzymes after experimental SAH</article-title>
          <source>J Neurol Sci</source>
          <year>1992</year>
          <volume>111</volume>
          <fpage>13</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1016/0022-510X(92)90106-U</pub-id>
          <pub-id pub-id-type="pmid">1402993</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR115">
        <label>115.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>ED</given-names>
            </name>
          </person-group>
          <article-title>A comparison of the effects of tirilazad on subarachnoid hemorrhage-induced blood&#x2013;brain barrier permeability in male and female rats</article-title>
          <source>J Stroke Cerebrovasc Dis</source>
          <year>1997</year>
          <volume>6</volume>
          <fpage>389</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="doi">10.1016/S1052-3057(97)80039-0</pub-id>
          <pub-id pub-id-type="pmid">17895039</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR116">
        <label>116.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kassell</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Haley</surname>
              <given-names>EC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Apperson-Hansen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand [see comments]</article-title>
          <source>J Neurosurg</source>
          <year>1996</year>
          <volume>84</volume>
          <fpage>221</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1996.84.2.0221</pub-id>
          <pub-id pub-id-type="pmid">8592224</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR117">
        <label>117.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>XS</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zuo</surname>
              <given-names>QL</given-names>
            </name>
            <name>
              <surname>Kuai</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Neuroprotective effects of edaravone on early brain injury in rats after subarachnoid hemorrhage</article-title>
          <source>Chin Med J (Engl)</source>
          <year>2009</year>
          <volume>122</volume>
          <fpage>1935</fpage>
          <lpage>1940</lpage>
          <pub-id pub-id-type="pmid">19781374</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR118">
        <label>118.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munakata</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ohkuma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimamura</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Asano</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Naraoka</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage</article-title>
          <source>Neurosurgery</source>
          <year>2009</year>
          <volume>64</volume>
          <fpage>423</fpage>
          <lpage>428</lpage>
          <pub-id pub-id-type="doi">10.1227/01.NEU.0000338067.83059.EB</pub-id>
          <pub-id pub-id-type="pmid">19240603</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR119">
        <label>119.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alksne</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Prevention of persistent cerebral smooth muscle contraction in response to whole blood</article-title>
          <source>Stroke</source>
          <year>1978</year>
          <volume>9</volume>
          <fpage>472</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="pmid">100906</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR120">
        <label>120.</label>
        <mixed-citation publication-type="other">Dorhout Mees SM, van den Bergh WM, Algra A, and Rinkel GJ (2007) Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev CD006184</mixed-citation>
      </ref>
      <ref id="CR121">
        <label>121.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toyoda</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Nakajima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nukui</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Changes in coagulation and fibrinolysis and effects of ticlopidine and cisternal drainage in the acute phase following aneurysm rupture</article-title>
          <source>Neurol Med Chir (Tokyo)</source>
          <year>1990</year>
          <volume>30</volume>
          <fpage>670</fpage>
          <lpage>675</lpage>
          <pub-id pub-id-type="doi">10.2176/nmc.30.670</pub-id>
          <pub-id pub-id-type="pmid">1708457</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR122">
        <label>122.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iso</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hennekens</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Stampfer</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Rexrode</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Colditz</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Speizer</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Willett</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Manson</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Prospective study of aspirin use and risk of stroke in women</article-title>
          <source>Stroke</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>1764</fpage>
          <lpage>1771</lpage>
          <pub-id pub-id-type="pmid">10471421</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR123">
        <label>123.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Juvela</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1995</year>
          <volume>82</volume>
          <fpage>945</fpage>
          <lpage>952</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1995.82.6.0945</pub-id>
          <pub-id pub-id-type="pmid">7760196</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR124">
        <label>124.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Afshar</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Pluta</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Boock</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Oldfield</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <article-title>Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>1995</year>
          <volume>83</volume>
          <fpage>118</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1995.83.1.0118</pub-id>
          <pub-id pub-id-type="pmid">7782826</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR125">
        <label>125.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tierney</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Clatterbuck</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Thai</surname>
              <given-names>QA</given-names>
            </name>
            <name>
              <surname>Rhines</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Tamargo</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer</article-title>
          <source>Neurosurgery</source>
          <year>2001</year>
          <volume>49</volume>
          <fpage>945</fpage>
          <lpage>951</lpage>
          <pub-id pub-id-type="doi">10.1097/00006123-200110000-00028</pub-id>
          <pub-id pub-id-type="pmid">11564257</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR126">
        <label>126.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Isotani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hirakawa</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>45</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1097/00005344-200001000-00006</pub-id>
          <pub-id pub-id-type="pmid">10630732</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR127">
        <label>127.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raabe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zimmermann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Setzer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vatter</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Berkefeld</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Seifert</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm</article-title>
          <source>Neurosurgery</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>1006</fpage>
          <lpage>1013</lpage>
          <pub-id pub-id-type="doi">10.1097/00006123-200205000-00013</pub-id>
          <pub-id pub-id-type="pmid">11950403</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR128">
        <label>128.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luders</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Weihl</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ghadge</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stoodley</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roos</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Macdonald</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Adenoviral gene transfer of nitric oxide synthase increases cerebral blood flow in rats</article-title>
          <source>Neurosurgery</source>
          <year>2000</year>
          <volume>47</volume>
          <fpage>1206</fpage>
          <lpage>1214</lpage>
          <pub-id pub-id-type="doi">10.1097/00006123-200011000-00039</pub-id>
          <pub-id pub-id-type="pmid">11063115</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR129">
        <label>129.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGirt</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Parra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sheng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pearlstein</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Laskowitz</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Pelligrino</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage</article-title>
          <source>Stroke</source>
          <year>2002</year>
          <volume>33</volume>
          <fpage>2950</fpage>
          <lpage>2956</lpage>
          <pub-id pub-id-type="doi">10.1161/01.STR.0000038986.68044.39</pub-id>
          <pub-id pub-id-type="pmid">12468796</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR130">
        <label>130.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGirt</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Blessing</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Nimjee</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Woodworth</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Graffagnino</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Laskowitz</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: a multivariate analysis of an institutional experience</article-title>
          <source>J Neurosurg</source>
          <year>2006</year>
          <volume>105</volume>
          <fpage>671</fpage>
          <lpage>674</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2006.105.5.671</pub-id>
          <pub-id pub-id-type="pmid">17121126</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR131">
        <label>131.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kreiter</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sciacca</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Naidech</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Commichau</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Fitzsimmons</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Janjua</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>ES</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study</article-title>
          <source>Neurosurgery</source>
          <year>2005</year>
          <volume>56</volume>
          <fpage>476</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="doi">10.1227/01.NEU.0000153925.96889.8A</pub-id>
          <pub-id pub-id-type="pmid">15730572</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR132">
        <label>132.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sobey</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Quan</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage</article-title>
          <source>Am J Physiol</source>
          <year>1999</year>
          <volume>277</volume>
          <fpage>H1718</fpage>
          <lpage>H1724</lpage>
          <pub-id pub-id-type="pmid">10564124</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR133">
        <label>133.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Platz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Barath</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Keller</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Valavanis</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Disruption of the blood&#x2013;brain barrier by intra-arterial administration of papaverine: a technical note</article-title>
          <source>Neuroradiology</source>
          <year>2008</year>
          <volume>50</volume>
          <fpage>1035</fpage>
          <lpage>1039</lpage>
          <pub-id pub-id-type="doi">10.1007/s00234-008-0455-x</pub-id>
          <pub-id pub-id-type="pmid">18791708</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR134">
        <label>134.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGirt</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Pradilla</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Legnani</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Thai</surname>
              <given-names>QA</given-names>
            </name>
            <name>
              <surname>Recinos</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Tamargo</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Clatterbuck</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm</article-title>
          <source>Neurosurgery</source>
          <year>2006</year>
          <volume>58</volume>
          <fpage>945</fpage>
          <lpage>951</lpage>
          <pub-id pub-id-type="doi">10.1227/01.NEU.0000210262.67628.7E</pub-id>
          <pub-id pub-id-type="pmid">16639331</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR135">
        <label>135.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gertz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Laufs</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Lindauer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Nickenig</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bohm</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dirnagl</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Endres</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Withdrawal of statin treatment abrogates stroke protection in mice</article-title>
          <source>Stroke</source>
          <year>2003</year>
          <volume>34</volume>
          <fpage>551</fpage>
          <lpage>557</lpage>
          <pub-id pub-id-type="doi">10.1161/01.STR.0000054055.28435.BF</pub-id>
          <pub-id pub-id-type="pmid">12574574</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR136">
        <label>136.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lynch</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>McGirt</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Floyd</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Coon</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Blessing</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Graffagnino</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Laskowitz</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial</article-title>
          <source>Stroke</source>
          <year>2005</year>
          <volume>36</volume>
          <issue>9</issue>
          <fpage>2024</fpage>
          <lpage>2026</lpage>
          <pub-id pub-id-type="doi">10.1161/01.STR.0000177879.11607.10</pub-id>
          <pub-id pub-id-type="pmid">16051891</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR137">
        <label>137.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vergouwen</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Meijers</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Geskus</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Coert</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stroes</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Poll</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Vermeulen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roos</surname>
              <given-names>YB</given-names>
            </name>
          </person-group>
          <article-title>Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2009</year>
          <volume>29</volume>
          <fpage>1444</fpage>
          <lpage>1453</lpage>
          <pub-id pub-id-type="doi">10.1038/jcbfm.2009.59</pub-id>
          <pub-id pub-id-type="pmid">19458605</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR138">
        <label>138.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kramer</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis</article-title>
          <source>Neurocrit Care</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>285</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="doi">10.1007/s12028-009-9306-9</pub-id>
          <pub-id pub-id-type="pmid">19921470</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR139">
        <label>139.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tapia-Perez</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Sanchez-Aguilar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The role of statins in neurosurgery</article-title>
          <source>Neurosurg Rev</source>
          <year>2010</year>
          <volume>33</volume>
          <fpage>259</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="doi">10.1007/s10143-010-0259-4</pub-id>
          <pub-id pub-id-type="pmid">20429022</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR140">
        <label>140.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackowski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Crockard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burnstack</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Russel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kristek</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>The time course of intracranial pathophysiological changes following experimental subarachnoid hemorrhage in the rat</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>1990</year>
          <volume>10</volume>
          <fpage>835</fpage>
          <lpage>839</lpage>
          <pub-id pub-id-type="pmid">2211877</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR141">
        <label>141.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rasmussen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hauerberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Waldemar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gjerris</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Juhler</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cerebral blood flow autoregulation in experimental subarachnoid haemorrhage in rat</article-title>
          <source>Acta Neurochir</source>
          <year>1992</year>
          <volume>119</volume>
          <fpage>128</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01541796</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR142">
        <label>142.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bederson</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>DiPerna</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>ALr</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vallabhajosyula</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Acute vasoconstriction after subarachnoid hemorrhage</article-title>
          <source>Neurosurgery</source>
          <year>1998</year>
          <volume>42</volume>
          <fpage>352</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="doi">10.1097/00006123-199802000-00091</pub-id>
          <pub-id pub-id-type="pmid">9482187</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR143">
        <label>143.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarrafzadeh</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Sakowitz</surname>
              <given-names>OW</given-names>
            </name>
            <name>
              <surname>Kiening</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Benndorf</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lanksch</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Unterberg</surname>
              <given-names>AW</given-names>
            </name>
          </person-group>
          <article-title>Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients?</article-title>
          <source>Crit Care Med</source>
          <year>2002</year>
          <volume>30</volume>
          <fpage>1062</fpage>
          <lpage>1070</lpage>
          <pub-id pub-id-type="doi">10.1097/00003246-200205000-00018</pub-id>
          <pub-id pub-id-type="pmid">12006804</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR144">
        <label>144.</label>
        <mixed-citation publication-type="other">Sehba FA, Flores R, Ono K, Suzuki H, Sawada MS, and Kanzawa T (2008) Expression of cytokines and neurotrophins after acute subarachnoid hemorrhage. Annual Stroke Conference 2008, Session: 126, P327</mixed-citation>
      </ref>
      <ref id="CR145">
        <label>145.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kamezaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yanaka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nagase</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nose</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Increased levels of lipid peroxides as predictive of symptomatic vasospasm and poor outcome after aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg</source>
          <year>2002</year>
          <volume>97</volume>
          <fpage>1302</fpage>
          <lpage>1305</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2002.97.6.1302</pub-id>
          <pub-id pub-id-type="pmid">12507127</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR146">
        <label>146.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirashima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Endo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takaku</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Sequential changes in the platelet count in patients with symptomatic vasospasm after subarachnoid hemorrhage</article-title>
          <source>Neurol Med Chir (Tokyo)</source>
          <year>1993</year>
          <volume>33</volume>
          <fpage>220</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="doi">10.2176/nmc.33.220</pub-id>
          <pub-id pub-id-type="pmid">7685852</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR147">
        <label>147.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trojanowski</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Early effects of experimental arterial subarachnoid haemorrhage on the cerebral circulation. Part I: Experimental subarachnoid haemorrhage in cat and its pathophysiological effects. Methods of regional cerebral blood flow measurement and evaluation of microcirculation</article-title>
          <source>Acta Neurochir</source>
          <year>1984</year>
          <volume>72</volume>
          <fpage>79</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01406816</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR148">
        <label>148.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hubschmann</surname>
              <given-names>OR</given-names>
            </name>
          </person-group>
          <article-title>The role of calcium in parenchymal cell injury in subarachnoid haemorrhage</article-title>
          <source>Neurol Res</source>
          <year>1987</year>
          <volume>9</volume>
          <fpage>265</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">2895904</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR149">
        <label>149.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sambrook</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hutchinson</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Aber</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Metabolic studies in subarachnoid haemorrhage and strokes. II. Serial changes in cerebrospinal fluid and plasma urea electrolytes and osmolality</article-title>
          <source>Brain</source>
          <year>1973</year>
          <volume>96</volume>
          <fpage>191</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/96.1.191</pub-id>
          <pub-id pub-id-type="pmid">4695722</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR150">
        <label>150.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holst</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mathiesen</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Electrolyte concentrations in serum and CSF following subarachnoid haemorrhage</article-title>
          <source>Br J Neurosurg</source>
          <year>1990</year>
          <volume>4</volume>
          <fpage>123</fpage>
          <lpage>126</lpage>
          <pub-id pub-id-type="doi">10.3109/02688699008992710</pub-id>
          <pub-id pub-id-type="pmid">2357281</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR151">
        <label>151.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaura</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Tani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Saido</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Minami</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Calpain&#x2013;calpastatin system of canine basilar artery in vasospasm</article-title>
          <source>J Neurosurg</source>
          <year>1993</year>
          <volume>79</volume>
          <fpage>537</fpage>
          <lpage>543</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1993.79.4.0537</pub-id>
          <pub-id pub-id-type="pmid">8410223</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR152">
        <label>152.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The role of p53 in brain edema after 24&#xA0;h of experimental subarachnoid hemorrhage in a rat model</article-title>
          <source>Exp Neurol</source>
          <year>2008</year>
          <volume>214</volume>
          <fpage>37</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.07.006</pub-id>
          <pub-id pub-id-type="pmid">18691572</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR153">
        <label>153.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zubkov</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Tibbs</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Clower</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ogihara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Morphological changes of cerebral arteries in a canine double hemorrhage model</article-title>
          <source>Neurosci Lett</source>
          <year>2002</year>
          <volume>326</volume>
          <fpage>137</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.1016/S0304-3940(02)00188-X</pub-id>
          <pub-id pub-id-type="pmid">12057847</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
